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Niemann-Pick type C (NPC) disease is characterized by accumulation and sequestration 
of unesterified cholesterol in the endocytic pathway and progressive neurodegeneration. 
The cellular mechanism for loss of neurons of the central nervous system (CNS) under 
NPC phenotype is still under investigation. Rab proteins constitute the largest branch of 
the Ras GTPase superfamily and regulate each of the four major steps in membrane traffic: 
vesicle budding, vesicle delivery, vesicle tethering, and are involved in modulation of 
cellular cholesterol transport and homeostasis.  
 
In this study, I demonstrate inhibition of intracellular cholesterol trafficking in primary 
neurons by class 2 amphiphiles, which mimics the major biochemical and cellular feature 
of NPC1, led to not only impaired mitochondrial function but also activation of the 
mitochondrial apoptosis pathway.  
 
In activation of this pathway, both cytochrome-c and Smac/Diablo are released but 
apoptosis-inducing factor (AIF) is not involved. Treatment of the neurons with taurine, a 
caspase-9 specific inhibitor, could prevent the amphiphile-induced apoptotic cell death, 
suggesting that formation of apoptosome, followed by caspase-9 and caspase-3 activation, 
might play a critical role in the neuronal death pathway.  
 
cAMP has been shown to improve the survival in vitro of several neuronal types when 
added to the medium. In this study, I demonstrate that significant upregulation of Rab7 
 ix
expression and mild increase of rab9 expression with treatment of cAMP and forskolin to 
primary neurons and NPC1 fibroblasts, through activation of ERK, leading to survival of 
cells. In this process, cholesterol trafficking is modulated, and cholesteryl ester is 
increased in both types of cells.  
 
In summary, this study show that cAMP and forskolin have effects on the endocytic 
trafficking via regulation of the expression of Rab GTPase, and may provide insight into 
the mechanism of the molecular basis of neurodegeneration in NPC1 disease and 
therapeutic strategies for treatment of this disorder. 
 x
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Chapter 1. Introduction 
 
 
1.1 Cholesterol trafficking and homeostasis   
 
Cholesterol is an essential component of animal cellular membranes and precursor for 
biosynthesis of steroid hormones and bile acids. The intracellular cholesterol homeostasis 
is essential for many biological functions of mammalian cells. At cellular level, 
cholesterol homeostasis is maintained by regulated cholesterol uptake, de novo synthesis, 
intracellular transport and efflux. 
 
 
Eukaryotic cells form the 27 carbon atom-bearing cholesterol molecule from scratch 
starting with acetate as substrate. Cholesterol synthesis is a complex biosynthetic process 
which takes place in the endoplasmic reticulum, and involves acetyl-CoA and other 
enzymes, many of which are located in the endoplasmic reticulum (ER) (Urbani and 
Simoni, 1990). The enzyme  3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) 
reductase catalyzes the rate-limiting reaction in cholesterol biosynthesis pathway (Brown 
and Goldsein, 1980). In the biosynthetic secretory pathway, cholesterol concentration is 
lowest in the ER. The ER is the primary site of cholesterol synthesis and esterification, 
and it is the crucial regulatory compartment in cholesterol homeostasis, although ER is a 
cholesterol-poor organelle, comprising only 0.5-1% of total cellular cholesterol (Lange et 
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al., 1999). Recent data indicate that excess free cholesterol may exert its cytotoxic effects 
via the ER (Feng et al., 2003). It increases through the Golgi apparatus, with the highest 
concentration in the plasma membrane (Liscum and Munn, 1999). Transport between ER 
and PM is dynamic, because it has been estimated that the entire PM cholesterol-pool 
cycles to the ER and back with a half-time of 40 minutes (Lange et al., 1993). 
 
 
The cholesterol content and the expression level of cholesterol-specific enzymes show 
strong region-specific variation (Bae et al, 1999; Runquist et al., 1995; Turley et al., 1998; 
Zhang et al., 1996;). The brain contains five to ten times more cholesterol than any other 
organ and this sterol represents 2–3% of the total weight and 20–30% of all lipids in the 
brain. There is solid evidence that most if not all of this cholesterol is produced in situ 
rather than imported from the blood (Edmond et al., 1991; Jurevics et al., 1995; Turley et 
al., 1998), probably because lipoprotein particles, which mediate the intercellular 
transport of sterols and other lipids, cannot pass the blood-brain barrier. Nervous tissue is 
capable of cholesterol synthesis and the synthesis rate and cholesterol content increase 
drastically during brain development (Dietschy et al., 2001; Sastry, 1985). 
 
Apart from de novo synthesis, cells can acquire cholesterol by uptake of lipoprotein 
(Simons and Ikonen, 2000) through specific receptors in the plasma membrane (Brown 
and Goldstein, 1986). LDL binds to LDL-receptors that cluster in clathrin-coated vesicles, 
which subsequently become uncoated. Four general compartments in the endocytic 
pathway, defined by different protein and lipid compositions: (1) early or sorting 
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endosomes; (2) the endocytic recycling compartment (ERC) or recycling endosomes; (3) 
late endosomes; and (4) lysosomes. Late endosomes are normally dynamic structures, but 
they become static, enlarged, and cholesterol-rich in NPC cells (Ko et al., 2001) 
 
Although the itinerary of the LDL receptor in this pathway is well-described, the fate of 
LDL-derived cholesterol is the subject of much investigation (Alberts et al., 2002; Brown 
and Goldstein, 1986). At the final stage of endocytosis, both proteins and lipids enter the 
lysosomes for subsequent metabolism, releasing unesterified cholesterol to other 
intracellular sites and plasma membrane (Fielding and Fielding, 1997). Lysosomes are 
thus generally regarded as the end-point of the endocytic pathway. Low-density 
lipoprotein particles contain apolipoprotein (Apo) B as major protein component and 
draw their load from newly synthesized material in the endoplasmic reticulum. The 
reverse cholesterol transport, whereby cells from different organs eliminate excess 
cholesterol through the liver, is mediated by high-density lipoprotein (HDL) particles. 
HDL particles contain ApoA1 and acquire cholesterol directly from the plasma 
membrane. This transfer is probably mediated by members of the ATP-binding cassette 
(ABC) transporter family (Dietschy and Turley, 2001; Schmitz and Orso, 2001),  
 
Regardless of whether cells acquire cholesterol by synthesis or uptake, the molecule must 
be distributed to the different cellular membrane compartments. Cholesterol moves 
against a steep concentration gradient to reach the PM, where cholesterol has important 
functions, by vesicular transport through the Golgi. ATP depletion or low temperature 
inhibited rapid ER to PM cholesterol transport (DeGrella et al., 1982; Urbani et al., 1990). 
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Excess cellular cholesterol from other compartments returns to the ER for esterification, 
through a negative feedback mechanism. The ER may also accommodate some excess 
free cholesterol via its large surface area and ability to synthesize phospholipids, thus 
maintaining an acceptable cholesterol-to-phospholipid ratio (Blanchette-Mackie, 2000; 
Tabas 2002). 
 
Cholesterol is also transported from endocytic recycling compartment (ERC) to PM via 
vesicular transportation and it also traffics in the opposite direction from PM to ERC, 
which is a rapid and ATP-independent non-vesicular transport (Hao et al., 2002). 
 
In humans, the central nervous system, being only 2% or less of the mass of a normal 
individual, is particularly enriched in unesterified cholesterol and contains approximately 
a quarter of all the unesterified cholesterol present in the body (Dietschy and Turley, 
2001). The neuronal cells acquire cholesterol mainly by de novo biosynthesis and, to a 
much less extent, by turnover among the glial cells and neurons probably involving 
receptor-mediated endocytosis, as the former secrets large amount of apolipoprotein E 
(ApoE) and ApoE receptors are abundantly found on the latter (Herz and Bock, 2002). 
Cholesterol in the brain may play an important role in synaptic development and 
plasticity, brain growth, neuron repair and remodeling, and even maintaining the normal 
function of this important organ (Dietschy and Turley, 2001; Herz and Bock 2002; 
Koudinov and Koudinova, 2001; Mauch et al., 2001).  
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The cholesterol content of cellular membranes is tightly controlled by elaborate 
mechanisms that balance the level of cholesterol synthesis, uptake and release. A 
prominent feedback pathway involves sterol-sensing elements in the membrane and 
proteolytic activation of transcription factors that enhance the expression of cholesterol 
synthesizing enzymes and lipoprotein receptors (Brown and Goldstein, 1999; Hampton 
2002; Sakai and Rawson 2001). 
 
The disruption of cholesterol homeostasis is related to many biological and pathological 
abnormalities. Excess cholesterol kills macrophages by caspase-dependent apoptosis 
(Tabas 2007). The enrichment of mitochondria in free cholesterol, resulting in decreased 
mitochondrial membrane fluidity. The homeostasis of cholesterol and its trafficking to 
mitochondria may be of relevance in the pathophysiology of encompasses alcoholic and 
non-alcoholic steatohepatitis (Garcia-Ruiz et al., 2006). By promoting cholesterol 
accumulation and plaque vulnerability and by locally regulating hemostasis, arterial mast 
cells in atherosclerotic lesions have the potential to contribute to the clinical outcomes of 
atherosclerosis, such as myocardial infarction and stroke. Recent research showed 
CLN6p deficiency caused cholesterol accumulation in lysosomes. Alterations in 
protein/lipid intracellular trafficking would affect the composition and function of 
endocytic compartments, including lysosomes. Dysfunctional endosomal/lysosomal 
vesicles may act as one of the triggers for apoptosis and cell death, and for a secondary 




1.2 Apoptosis and neurodegenerative diseases 
 
Cell death has been divided into two general groups: apoptosis, a programmed cell death 
in which the cell plays an active role; and passive necrotic cell death. Morphologically, 
cells typically round up, form blebs, undergo zeiosis (an appearance reminiscent of 
boiling), chromatin condensation, nuclear fragmentation, and the breaking off of cellular 
fragments called apoptotic bodies. Phosphatidylserine, normally placed asymmetrically 
such that it faces internally on the plasma membrane (due to a flipase that flips the 
phosphatidylserine so that it faces internally), appears externally during apoptosis (Fadok 
et al., 1992). Apoptosis plays a role in tissue remodeling during normal development of 
the mammalian nervous system (Nijhawan 2000). Caspases are cysteine proteases that 
mediate apoptosis in a wide range of cell systems, including neuronal injury. It is largely 
accepted that caspases play a key role in both the initiation and execution pathways of 
apoptosis. In particular, caspase-3 has been implicated as a key cell-death protease 
involved in the execution phase of apoptosis (Earnshaw 1999; Thornberry and Lazebnik 
1998; Yuan et al., 1993).  
 
Upon activation, caspases cleave a variety of intracellular polypeptides, including major 
structural elements of the cytoplasm and nucleus, components of the DNA repair 
machinery, and a number of protein kinases, which then lead to the stereotypic 
morphological and biochemical changes that characterize apoptotic cell death. 
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Necrosis is generally characterized by early swelling of the cytoplasm and disintegration 
of cellular structures, which ultimately culminate in cell lysis and subsequent release of 
cellular debris into the extracellular space. Necrosis occurs following severe cellular 
injury and is usually associated with an inflammatory response (Dive et al., 1992; Searle 
et al., 1982).  
 
The biochemical mediation of apoptosis occurs through two general pathways: an 
intrinsic pathway, mediated by the mitochondrial release of cytochrome-C and resultant 
activation of caspase-9; and an extrinsic pathway, originating from the activation of cell 
surface death receptors such as Fas, and resulting in the activation of caspase-8 or 
caspase-10 (Salvesen and Dixit 1997). 
 
Following release from the mitochondria, cytochrome-C interacts with a cytosolic protein, 
Apaf-1, via the WD-40 repeats of Apaf-1, leading to the exposure of a (d) ATP-binding 
site on Apaf-1. Occupation of this (d) ATP-binding site induces a conformational change 
that results in heptamerization. The resultant exposure of the Apaf-1 caspase activation 
and recruitment domain (CARD) recruits caspase-9 into this apoptosomal complex, and 
the resulting induced proximity of caspase-9 molecules leads to their activation 
(Boatright et al., 2003) 
 
Neurodegenerative diseases are characterized by the progressive death of neurons and 
result in memory loss, movement problems, cognitive deficits, emotional alterations 
and behavioral problems. Neurodegenerative disorders affect neural activities at many 
levels. Neurodegenerative disorders can disrupt molecular pathways, synapses, neuronal 
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subpopulations and local circuits in specific brain regions, as well as higher-order neural 
networks. Abnormal network activities may result in a vicious cycle, further impairing 
the integrity and functions of neurons and synapses, for example, through aberrant 
excitation or inhibition. Neurodegenerative conditions are the result of multiple specific 
processes, many of which are related to the cellular signaling events specific to the brain. 
Neuronal cell death via apoptosis is believed to be one of the chief events involved 
in Alzheimer's disease (AD), other neurodegenerative diseases (Cotman et al., 1995; 
Eckert et al., 2003; Friedlander et al., 2003; Nijhawan et al., 2000; Yuan et al., 2000). 
 
Cholesterol homeostasis breakdown is the unifying primary cause and the major target 
for therapy of sporadic and familial AD, neuromuscular diseases, Niemann-Pick type C 
disease and Down syndrome. Recent work has shown neuronal cholesterol accumulation 
in early postnatal NPC1- deficient mice, suggesting a primary role for cholesterol in brain 
(Reid et al., 2004). 
 
Niemann-Pick disease type C (NPC) is a hereditary autosomal recessive lipid storage 
disorder characterized by cholesterol accumulation in the liver, spleen, and central 
nervous system and progressive neurodegeneration and premature neuronal cell loss 
(Patterso et al. 2001).Mutations in two independent genes result in the clinical and 
biochemical NPC phenotype (Vanier MT, et al., 1996). NPC disease is biochemically 
distinct from Niemann-Pick disease type A and type B, which are caused by genetic 
defects in sphinogomyelinase activity (Brady et al., 1966). This disorder is caused by 
mutation in the NPC1 gene in about 95% of the cases, or in the NPC2 gene in the rest of 
 9
5% cases. The human NPC1 gene was identified and cloned three decades ago (Carstea et 
al. 1997). 
 
The NPC1 disease gene encodes a 1278 amino acid, polytopic protein with 13 
transmembrane domains. The region between amino acids 615 and 797 shares 
approximately 30% identity with the sterol-sensing domains (SSD) of 3-hydroxy-3-
methylglutaryl CoA (HMGCoA) reductase, SREBP cleavage-activating activating 
protein (SCAP), and Patched (Davies and Ioannou , 2000).  
 
The amino terminus contains a region with a leucine zipper motif (amino acids 55–165) 
that is highly conserved among NPC1 orthologs and is referred to as the NPC1 domain. 
Within NPC1 there is a large, cysteine-rich luminal loop (amino acids 855–1098), 
which contains a ring-finger motif that may mediate protein– protein interactions 
(Watari et al., 2000).  
 
NPC1 also possesses a carboxyl-terminal dileucine motif that is required for proper 
targeting of the protein to the endocytic pathway (Watari et al. 1999). ). Studies of the 
subcellular distribution of NPC1 localize the protein to a late endosomal compartment 
that is lysosome-associated membrane protein-2 positive, Rab7 positive, and cation-
independent mannose-6-P receptor negative (Frolov et al. 2001; Higgins et al., 1999; 
Neufeld et al. 1999; Zhang et al. 2001a). Messenger RNA encoding NPC1 is present in 
neurons in vivo, with remarkable regional differences in the expression level (Falk T, 
1999; Prasad A, 2000). The subcellular localization of the NPC protein has showed 
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depending on the adaptor complex AP-3 (Berger et al, 2007). NPC1 could function as a 
cholesterol pump, or it could affect localization of another lipid with cholesterol 
following passively. Recent reports showed that NPC1 protein influences the delivery of 
cholesterol to the sterol regulatory element binding protein (SREBP):SREBP cleavage 
activation protein (SCAP) complex (Guo et al., 2008), purified NPC1 protein bound 
cholesterol and oxysterols to a 1278-amino acid membrane protein (Infante et al., 2007).  
 
 
The NPC2 disease gene encodes a 132 amino acid-soluble lysosomal protein that was 
identified through a proteomic survey of the lysosome (Naureckiene et al. 2000).  
NPC2 is a soluble cholesterol-binding protein in the lumen of late endosomes and 
lysosomes (Naureckiene et al., 2000; Ko et al., 2003). Because late endosomes have 
internal membranes, NPC2 could transfer cholesterol from these to the limiting 
membrane, where cholesterol efflux occur (Prinz 2002). The NPC2 protein has been 
shown to specifically bind cholesterol with a 1:1 stoichiometry and submicromolar 
affinity (Friedland 2003; Ko et al., 2003), although it has no apparent homology with 
other cholesterol binding proteins, such as sterol carrier protein 2, caveolin, StAR protein, 
or MLN64. The structure of the apo form of bovine NPC2 has been solved, revealing an 
immunoglobulin-like fold that is stabilized by three disulfide bonds, as well as a pocket 
that has been proposed to bind cholesterol (Friedland et al. 2003). Mutational analysis of 
residues surrounding this hydrophobic pocket has identified single amino acid 
substitutions that prevent both cholesterol binding and restoration of cholesterol 
trafficking in NPC2 mutant cells (Ko et al. 2003).  
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The NPC phenotype can also be reproduced by treatment of normal cells with steroids 
like progesterone or with hydrophobic amines (class II amphiphiles) like U18666A. The 
mechanism of U18666A action is unknown, a putative membrane protein-binding site has 
been described but not identified (Underwood et al., 1996).  
 
1.3  Endocytotic pathway and Rab proteins 
 
Members of the Rab family of small GTPases are involved in multiple trafficking events 
in both endocytotic and biosynthetic pathways, and are located in specific intracellular 
compartments. During dynamic trafficking processes, Rab domains get into contact via 
their effectors, generating directional Rab cascades which can result in Rab conversion 
accompanying cargo transport and organelle maturation. 
 
Rab proteins and Rab-associated proteins play their important role in hypopigmentation 
(Griscelli syndrome), eye defects (Choroideremia, Warburg Micro syndrome and 
Martsolf syndrome), disturbed immune function (Griscelli syndrome and Charcot-Marie-
Tooth disease) and neurological dysfunction (X-linked non-specific mental retardation, 
Charcot-Marie-Tooth disease, Warburg Micro syndrome and Martsolf syndrome). 
Alterations in Rab function play an important role in the progression of multifactorial 




The rabs, which are related to ras GTPase, are involved in regulating vesicular traffic. 
They are a large family in eukaryotes, with approximate 60 rabs in the human genome 
(Sabra et al., 2002). Rab proteins are regulators of membrane traffic. They act by cycling 
between GTP-bound active states to GDP-bound inactive states. When Rabs are bound to 
GTP, they recruit other proteins to membranes that regulate vesicle budding, the selection 
of cargo, vesicle docking, and fusion (Edinger et al., 2003), and inactivation by GAPs 
(Grosshans et al., 2006; Pfeffer and Aivazian, 2004; Zerial and McBride, 2001). 
 
Individual rab proteins are found on distinct organelles of the secretory and endocytic 
apparatus, suggesting that each protein controls a different step of membrane traffic. The 
endocytic pathway can be dissected into three distinct Rab-specific stages; the (early) 
endosome (Rab5), the sorting/recycling endosome (Rab4, Rab11), and the 
lysosome/vacuole as the target organelle for degradation (Rab7). Clathrin coated vesicle 
(CCV) mediated transport in the early endocytic pathway is regulated by Rab5, whereas 
recycling processes, during which internalized material is transported back to the plasma 
membrane, are regulated by Rab4 at the level of the early endosome and Rab11 on 
recycling endosomes. Rab domains on organelles are not static, but merge in a dynamic 
manner during protein transport (Pfeffer et al., 2003; Zerial et al., 2001; Zhao et al., 
2002). However, many of the details of rab function are not fully understood.  
 
Rab7 functions in the endocytic pathway of mammalian cells by regulating traffic from 
early to late endosomes and lysosomes. It has previously been shown that interfering with 
rab7 function inhibits this transport step, thereby blocking traffic from the cell surface to 
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lysosomes and preventing lyosomal degradation (Feng et al., 1995; Vitelli et al., 1997). A 
key role of rab7 may be the regulation of the level of functional proteins at the cell 
surface. Even if this activity is not necessary for cell survival, it may well be required for 
the other function of cells in tissues and organs (Edinger et al., 2003).  Evidence from a 
study of osteoclast polarization and bone resorption also showed Rab7, a small GTPase 
that is associated with late endosomes, is highly expressed and is predominantly localized 
at the ruffled border in bone-resorbing osteoclasts. The late endocytotic pathway is 
involved in the osteoclast polarization and bone resorption, in which Rab7 is important in 
osteoclast function (Zhao et al., 2001).  
 
Overexpression of wild-type Rab7 or Rab9 (but not Rab11) in Niemann-Pick type C  
lipid storage disease fibroblasts resulted in correction of lipid trafficking defects, 
including restoration of Golgi targeting of fluorescent lactosylceramide and endogenous 
GM(1) ganglioside, and a dramatic reduction in intracellular cholesterol stores 
(Choudhury et al., 2002). Similar result was shown by Narita et al. that correction of 
membrane traffic in NPC cells by Rab9 overexpression that may lead to new therapeutic 
approaches for treatment of this disease (Narita et al., 2005). 
 
Cholesterol contributes to regulate the Rab7 cycle, and that Rab7 in turn controls the net 
movement of late endocytic elements. Motor functions can be regulated by the membrane 
lipid composition via the Rab7 cycle (Lebrand et al., 2002; Gurenberg et al., 2002) 
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Along the endocytic  pathway, Rab5a is a rate-limiting catalyst of internalization, and 
Rab7 controls trafficking through late endosomes to lysosomes. Rab5a and Rab7 in 
autonomous thyroid adenomas (where the cAMP cascade is constitutively activated). 
Particulate Rab7 and iodine shifted toward lysosomal fractions, indicating that 
progression along the degradation pathway also was promoted. Thyroid-stimulating 
hormone or forskolin increased Rab5a and Rab7 but not Rab8 expression. This result 
suggested that thyroid-stimulating hormone, via cAMP, enhances the expression of 
Rab5a and Rab7, which promote Tg endocytosis and transfer to lysosomes, respectively, 
resulting in accelerated thyroid hormone production (Croizet-Berger et al., 2002).  
 
Rab11-mediated ERC cholesterol accumulation decreases ACAT activity about 40%, 
both in the presence and absence of LDL, but does not affect esterification of cholesterol 
delivered directly to the PM (Holtta-Vuori et al., 2002). 
 
In yeast, the Ypt1 protein (a homolog of human Rab1) functions at the ER-to-cis Golgi 
and cis-to-medial Golgi trafficking step, Ypt31 and its homolog Ypt32 (both homologs of 
human Rab11) are important for the exit from the Golgi apparatus, and the Sec4 protein 
controls the traffic of vesicles from the trans-Golgi network (TGN) to the plasma 
membrane (Cao et al., 1998; Guo et al., 1999; Ortiz et al., 2002; Suvorova et al., 2002). 
 
Evidence for a Rab–tether cascade from the Golgi to the plasma membrane has been 
presented. On the secretory vesicles, Ypt32 recruits Sec2, to exocytic vesicles, which in 
turn can recruit the Rab Sec4 to drive exocytosis Sec4-GTP then binds to the exocyst, a 
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large eight-subunit complex that tethers vesicles to the plasma membrane (Guo 1999; 
Ortiz 2002). 
 
Figure 1.1 Rab proteins involved in different vesicles transportation. 
ER: endoplasmic reticulum; TGN:  trans-Golgi network; CV: constitutive secretory 
vesicles; RV: regulated secretory vesicles; M: melanosomes;  EE: early endosomes;  LE: 



























1.4. Cellular signaling and cAMP 
 
Cyclic AMP is generated by adenylyl cyclases from ATP and is degraded by 
phosphodiesterases (Tasken and Aandahl, 2004). Mammals express one soluble and nine 
transmembrane isoforms of adenylyl cyclase (Chen et al., 2000; Cooper, 2003).Cell  
permeable analogues of cAMP have been shown to improve the survival of cells (Michel 
et al., 1996; Nakao 1998; Schildberg et al., 2005; Vaudry et al., 1998). 
 
Promotion of cell survival by cAMP or forskolin could be via ERK1/2 signaling. ERKs 
are members of the mitogen-activated protein kinase superfamily, have been well 
characterized and are known to be involved in cell survival (Jiang et al., 2005; Jin et al., 
2002; Park and Cho 2006; Passeron et al., 2008; Zhang and Abdel-Rahman 2008).  
 
Especially, ERKs are involved in a wide range of neuronal functions including 
differentiation, synaptic plasticity, survival, migration (Thelen et al, 2002), and long-term 
changes in gene expression (Hevroni et al., 1998) that may underlie aspects of learning 
and memory (Impey et al., 1999. Gobert D, 2008). For example, cAMP signaling can 
regulate the sensitivity of the axon to netrin-1 or cause it to switch from being an 
attractant to a repellent cue (Ming et al., 1997; Hopker et al., 1999; Moore and Kennedy, 
2006). Axons of developing mammalian neurons contain mRNA encoding the cAMP-
responsive element (CRE)-binding protein (CREB). CREB is translated within axons in 
response to nerve growth factor (NGF) and is retrogradely trafficked to the cell body. 
Axonal derived CREB enables specific transcriptional responses to signaling events at 
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distal axons which promotes neuronal survival (Llewellyn JC, et al., 2008). It has also 
suggested that the elevation of intracellular cAMP level promotes the trophic 
responsiveness of axotomized RGCs. Thus, different neurotrophic factors, such as a brain 
derived neurotrophic factors and ciliary neurotrophic factor, have been used in 
combination with cAMP to promote the survival of axotomized RGCs (Cui 2003; 
Mansour-Robaey 1994; Watanabe 2003). Cilostazol was reported to promote survival of 
axotomized retinal ganglion cells in adult rats. The main pharmacological effect of CLZ 
is to increase the intracellular cAMP level by blocking the hydrolysis of cAMP by 
phosphodiesterase-3 (Kashimoto et al., 2008). Elevation of cAMP in mesenchymal stem 
cells transiently upregulates neural markers and improve cellular adaptation to changes in 
culture conditions (Rooney et al., 2008).   
 
On the contrary, increased cAMP levels enhanced Bax translocation to the mitochondria, 
resulting in the release of cytochrome c, caspase-3 activation, and apoptosis induction 
(Hsiung et al., 2008). cAMP increased the spontaneous release and decreased the KCl-
induced release of [3H]-1-methyl-4-phenylpyridinium and dopamine and suggested that 
cAMP impairs the vesicular monoamine transporter (Ribeiro et al., 2002). 
 
 
1.5. Current therapeutic strategies on NPC1 disease 
Attempts at therapy on Niemann–Pick Type C disease to date have focused on reduction 
of the accumulating molecules that are presumed to have direct or indirect toxic effects 
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and such therapeutic approaches to bypass the cholesterol trafficking defect in NPC1 
disease might delay disease progression.  
 
Inhibition of glycosphingolipids (GSLs) synthesis in NPC cells with N-
butyldeoxygalactonojirimycin led to marked decreases in GSL but only small decreases 
in cholesterol levels. Both annexin 2 and 6, membrane-associated proteins that are 
important in endocytic trafficking, show distorted distributions in NPC cells. Altered 
BODIPY lactosylceramide targeting, decreased endocytic uptake of a fluid phase marker, 
and mistargeting of annexin 2 (phenotypes associated with NPC) are reversed by 
inhibition of GSL synthesis. It is suggested that accumulating GSL is part of a 
mislocalized membrane microdomain and is responsible for the deficit in endocytic 
trafficking found in NPC disease (te Vruchte et al., 2004). Study showed partial blockage 
of sterol biosynthesis with a squalene synthase inhibitor CP-340868 in early postnatal 
NPC null mice brains reduces neuronal cholesterol accumulation, reduces GM3 
ganglioside accumulation, and diminishes astrogliosis in the brain but may inhibit myelin 
maturation (Reid et al., 2007). Recently, the oral medication miglustat has been offered 
as a possible therapy aimed at reducing pathological substrate accumulation on a 3-years-
old NPC1 patient, but the outcome of such trial has far from conclusive (Paciorkowski et 
al., 2008).  
 
Neurosteroids are necessary for neuronal and glial function, alterations in sequestration of 
intracellular cholesterol may result in altered neurosteroidogenesis, and subsequently 
alter neuronal and glial function. A few studies has used neurosteroid to treat NPC1 
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mouse. Neurosteroid allopregnanolone (ALLO) treated NP-C mice had substantially 
increased survival and delays in neurologic impairments, coinciding with marked 
improvements in neuronal survival, and reduction of gangliosides. These data suggest 
that neurosteroids play an important role in brain development and maturation and may 
be an effective therapy for NP-C and perhaps other lysosomal storage diseases (Mellon et 
al., 2004). 
 
Langmade SJ used neurosteroid allopregnanolone (ALLO) and T0901317, a synthetic 
oxysterol ligand to treat on npc1 (-/-) mice. They showed ALLO and T0901317 therapy 
preserved Purkinje cells, suppressed cerebellar expression of microglial-associated genes 
and inflammatory mediators, and reduced infiltration of activated microglia in the 
cerebellar tissue, and this compound has the ability to activate pregnane X receptor-
dependent pathways in vivo, therefore suggestion was raised that treatment with pregnane 
X receptor ligands may be useful clinically in delaying the progressive neurodegeneration 
in human NPC disease (Langmade 2006). Griffin et al. used concentration of 
pregnenolone, DHEA and allopregnanolone were all significantly less in brains of NP-C 
mice than they were in brains of age-matched wild type mice. Adult NP-C brains had 
significantly diminished   expression of P450scc, 3βHSD, 5α reductase and 3α HSD. This 
reduction in expression of these neurosteroidogenic enzymes was seen in the cortex and 
in the cerebellum.Treatment with allopregnanolone – providing the neurosteroid in 
drinking water, as a timed-release pellet, and as an injection, and each treatment had 
some efficacy (Griffin et al., 2004). Allopregnanolone functions is by augmentation of 
GABAA receptor channel opening, through alteration of the kinetics of entry to and exit 
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from desensitized states of the receptor (Zhu et al., 1996 and 1997), and it has effect on 
treatment of NP-C mice, but more effective in combination with a synthetic LXR ligand 
(Langmade et al., 2006), however, another GABA-ergic neurosteroid, ganaxolone, 
treatment was not as effective. 
 
Genetic therapy may be a potential approach to rescue neurodegeneration. Recent study 
showed that a prion-promoter-driven Npc1 cDNA transgene could rescue 
neurodegeneration in Niemann-Pick C mice and overexpression of NPC1 is not harmful 





1.6. The aim and significance of this study 
Cholesterol plays many well-described roles within the cell, but how cholesterol moves 
to and from key organelles to perform these roles is not as well-known. The cellular 
mechanism for loss of neurons of the central nervous system (CNS) under NPC 
phenotype is still under investigation. Most current models of NPC involve defective or 
slowed cholesterol efflux from late endosomes, but the precise defect is unknown. It is 
not known whether cholesterol accumulation and neuronal apoptosis caused by 
progesterone or U18666A treatment affects adversely the mitochondrial functions, and if 
so whether mitochondrial dysfunction triggers the cascade of neuronal apoptosis.  
Attempts at therapy on Niemann–Pick Type C disease to date have focused on reduction 
of the accumulating molecules that are presumed to have direct or indirect toxic effects 
and such therapeutic approaches to bypass the cholesterol trafficking defect in NPC1 
disease might delay disease progression. Few reports that genetic intervention on NPC1 
could be a potential approach to rescue neurodegeneration. Our study aims to contribute 
to the understanding of cholesterol  in the process of neurodegeneration and the 
development of effective prevention and therapeutic intervention for neurodegenerative 
diseases.  
In this project, the following studies will be carried out: 
(1) The effect of progesterone and U18666A on cholesterol homeostasis of primary 
cultured embryonic cortical neurons and the consequence of such cholesterol 
accumulation and sequestration.  
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(2) The mechanism of intracellular cholesterol accumulation induced neuronal apotosis. 
 
(3) The effect of cAMP and forskolin on rescue of neuronal injury induced by U18666A. 
 
(4)  The mechanism of restoration of cholesterol homeostasis.  
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Progesterone, taurine, poly-D-lysine, butyl-cyclic AMP, forskolin and mouse monoclonal 
anti-ß-actin antibody, and minimum essential medium eagles purchased from Sigma (St. 
Louis, MO).  
 
3β-[2-(diethylamino) ethoxy] androst-5-en-17-one (U18886A) was from BioMol 
(Plymouth Meeting, PA).  
 
NeurobasalTM (NB) growth medium, B27 supplement, glutamax-I, Alex Fluor® 
secondanary antibodies,  EnzChek® caspase-3 assay kit, MitoTracker® Green, propidium 
iodide, Hoechst 33342 and mouse monoclonal anti-COX-IV antibody were from 
Invitrogen (Grand Island, NY).  
 
Protein assay kit was obtained from Bio-Rad (Hercules, CA). Polyvinylidene difluoride 
(PVDF) membranes and SuperSignal enhanced chemiluminescence’s reagent were 
bought from Pierce (Rockford, IL).  
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Mouse monoclonal anti-cytochrome c and anti-MAP2 antibodies, rabbit polyclonal anti-
Rab5, anti-Rab7, anti-Rab9 and anti-Rab11 antibodies were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA).  
 
Mouse monoclonal anti-caspase-3 and anti-nucleoporin P62 antibodies were from BD 
PharMingen (San Diego, CA).  
 
Rabbit polyclonal anti-AIF, mouse monoclonal anti-Smac/Diablo and anti-caspase-9 
antibodies, Rabbit polyclonal anti-phosphoERK and non-phosphoERK were purchased 
from Cell Signaling Technology (Beverly, MA).  
 
The in situ cell death detection kit (TUNEL), protease inhibitor and phosphotase inhibitor 
were from Roche (Basel, Switzerland). 
 
Caspase-3 specific inhibitor Z-DEVD-FMK was obtained from Merck (Darmstadt, 
Germany) 
 
2′-Amino-3′-methoxyflavone (PD98059) and fluorTM save reagent was from Calbiochem 
(San Diego, CA). 
 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) was from 
Duchefa (Harlem, The Netherlands).  
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The ApoGlow Rapid Apoptosis Screening Kit was from Cambrex (East Rutherford, NJ). 
 
BCS scintillation cocktail was purchased from Amersham (Little Chalfone, 
Buckinghamshire, England). 
 
Rabbit anti-goat IgG HRP conjugated, goat anti-mouse IgG HRP conjugated, Goat anti-
rabbit IgG HRP conjugated, prestained broad range precision protein standards, 
ammonium persulfate, acrylamide/Bis solution, Bromophenol blue and RC DC protein 
assay kit were purchased from Bio-Rad (Hercules, California). 
 
2.2. Instruments and other general comsumables 
 
The instruments and general consumables used in this work include  
BECKMAN LS6000 Scintillation Counter (Beckman Coulter, Inc., 4300N. Harbor 
Boulevard, Fullerton, CA), 
Biological Safety Cabinet Class II (Gelman Science Inc., Washtenaw County Circuit 
Court),  
CO2 Incubator (Heraeus Kulzer Australia Pty Ltd., Unit 3, 4 Gibbes Street, Chatswood, 
Australia),  
Dry-Bath (Medical Research Council, 20 Park Crescent, London, W1B 1Al, UK), 
Eppendorf Centrifuge 5810R (B.BRAUN, postfach 1120, 34209 Melsungen, Germany), 
pH meter (Beckman Coulter),  
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OLYMPUS IX71 Fluorescence Microscope, OLYMPUS FV300 and FV500 laser 
scanning confocal microscope (Olympus Technologies Singapore Pte Ltd, 41 Science 
Park Road, #04-17/18, The Gemini, Singaproe Science Park II, Singapore), Orbital 
Shaker 100 (ARMALAB, LLC, Bethesda, MD),  
Oven, Water Bath (MEMMERT, GmbH Co. KG, Schwabach, Germany),  
PowerPac Basic Power Supply 100 (Bio-Rad Laborateories, 2000 Alfred Nobel Drive, 
Hercules, California),  
Vortexer (VWR Scientific, 1310 Goshen Parkway, West Chester, PA),  
Ultrasonic Water Bath (ITS Science and Medical, 219 Henderson Road, Henderson 
Industrial Park, Singapore),  
Blue MAXIM Polypropylene conical tube, Serological Pipette (Becton Dickinson 
Labware, Becton Dickinson and Company, Franklin Lakes, NJ, USA),  
Fast Turn Cap Mini PolyQ Vial (Beckman Coulter, Inc., 4300 N. Harbor Boulevard, 
Fullerton, CA),  














Swiss Albino mouse, pregnant with estimated 15 days gestation, were housed in NUS 
animal holding unit. 
 
2.3.2. Isolation and digestion media 
 
The isolation and digestion media for neuronal cells were prepared as followings:  
Hank’s balanced salt solution (HBSS) was purchased from Invitrogen. Solution I was  
HBSS medium with 0.3% BSA (w/v) and 1.2 mM MgSO4. Solution II was HBSS 
medium with 0.02% trypsin (w/v), 0.3% BSA (w/v), 0.0008% (w/v) DNaseI and 2.7 mM 
MgSO4. Solution III was HBSS medium with 0.05% soybean trypsin inhibitor (w/v), 
0.3% BSA, 0.0008% DNaseI (w/v) and 2.7 mM MgSO4. Solution IV was HBSS medium 
with 0.008% soybean trypsin inhibitor (w/v), 0.3% BSA, 0.0008% DNaseI (w/v) and 
1.44 mM MgSO4. All solutions were filtered through 0.2 μm filter unit.  
 
2.3.3. Culture medium 
 
Neuronal plating medium 
Dulbecco’s Modified Eagle Medium supplemented with heat inactivated fetal bovine 
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serum (10%, v/v), glutamine (2mM), penicillin (100 unit/ml) and streptomycin (100 
μg/ml). 
 
Neurobasal with B27 medium 
NeurobasalTM medium supplemented with B27 (2%, v/v), glutamax-I (0.025%, v/v), 
penicillin (100 unit/ml) and streptomycin (100 μg/ml). 
             
 
2.3.4. Isolation procedure 
 
The Brains were obtained from E15 embryos and meninges were removed The 























              
Dorsal view of isolated brain.  
c: cerebral hemisphere; m:midbrain 
The meninges were striped away by forceps. Left and right hemispheres 
















































                   
 
Medial view of left part of brain.  
c: cerebral hemisphere; m: midbrain;  
t: thalamus. 
The midbrain and thalamus were removed by forceps. 
              
Medial view of cerebral hemisphere.   
s: basal ganglia. 
Cut through the dotted line to remove hippocampus.
                      
 
Mdical view of cerebral hemisphere after 
hippocampus were removed. n: neocortex; v: 
ventricle; s: basal ganglia. 






























The neocortices were collected into 50 ml of solution I and centrifuged at 1000 rpm for 1 
min at 15ºC. The supernatant was discarded, and 20 ml of solution II were added to the 
pellet. The neocortices were incubated in 37oC water bath for 5 min. 
 
Twenty ml of solution IV were then immediately added into the tube to prevent over 
digestion. The neocortices were centrifuged at 1000 rpm for 5 min at 15ºC. Supernatant 
was discarded and 20 ml of solution III were added to the tube. A syringe (20 ml in size) 
fitted with a 14 G needle was used to dissociate neurons by gently aspirating for 10 
                       
Medial view of neocortex separated from the basal 
ganglia, except for its most posterior part. 
The neocortex was completely separated from the basal ganglia and was now 
ready for trypsin digestion. 
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strokes. The neuronal cell suspension was transferred to a new tube by Gilson 1ml pipette 
and the last 0.3ml of cell suspension at the bottom of tube was discarded.  
The neurons were then centrifuged at 1000 rpm for 5min at 15ºC. The collected neurons 
were resuspended with plating medium and the cells were ready for counting and seeding. 
The neurons were cultured in neurobasal and B27 medium from day one in vitro (DIV1) 
onward. 
 
2.3.5. Culture vessels 
 
Poly-D-lysine (PDL) was used to coat the surface of culture vessels. 0.1mg/ml PDL in 
double distilled H2O was filtered through 0.2 nm filter unit and 2 ml, 1ml, and 0.5ml of 
PDL was applied to each well of 6-well, 12-well, and 24-well culture plate, respectively. 
The plates was left in CO2 incubator overnight, and washed with double distilled H2O 
three time. After air-dried, the PDL coated plate was ready to use. Similar procedure was 




2.3.6. Cell counting and seeding 
 
Trypan blue stain (Sigma) and a hemocytometer was used to determine total cell counts 
and viable cell numbers. Trypan blue is one of several stains recommended for use in 
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exclusion procedures for viable cell counting. This method is based on the principle that 
live cells do not take up the dye, whereas dead cells do.  
 
A cell suspension in neuronal plating medium, was mixed with same volume of 0.4% 
(w/v) trypan blue solution (dilution factor = 2), which was then stood for 5-15 min. 
 
With the coverslip in place, a small amount of trypan blue stained cell suspension 
mixture was transferred to both chambers of the hemocytometer (Bright line counting 
chamber, Hausser Scientific, Horsham, PA). While transferring the cell suspension, the 
edge of the coverslip was carefully touched with the pipette tip and allowed each 
chamber to fill by capillary action. 
 
The cells were counted in the two 1 mm center square and eight 1 mm corner squares. 
Each square of the hemocytometer, with coverslip in place, represents a total volume of 
0.1 mm3 that is equivalent to approximately 10-4 ml. Therefore, cells per ml = the average 
count per square x dilution factor x 104.  
 
2.3.7. Cell viability assay  
 
Cell viability was measured by the MTT method (Hansen et al., 1989). In brief, MTT 
(500 g/ml) was added to cells and incubation was continued for 30 min at 37ºC. The 
culture medium and MTT in excess were removed and dimethyl sulphoxide (DMSO) was 
added to extract the MTT formazan formed by mitochondrial dehydrogenases which are 
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active only in live cells (Denizot and Lang, 1986; Hansen et al., 1989). Absorbance of the 
homogeneous extracts was read at 550 nm with a microplate reader (SpectraMax190, 
Molecular Devices). Cell viability was normalized relative to the control cells, whose 
viability was taken as 100%, treated for the same period with the corresponding vehicle 
(0.03% ethanol + 0.02% DMSO). 
 
2.3.8. Cell treatment 
The neurons were cultured in neurobasal and B27 medium from DIV1 onward. 
Neurons were treated with progesterone (50 μM) or U18666A (2 μg/ml) in the presence 
or absence of Taurine (20 μΜ), cAMP (0.3 mM), forskolin (20 μM) and/or PD98666A 







2.4. Cell line culture 
 
2.4.1. Cell source 
 
NPC1 fibroblasts (npc-/-, GM3123) were purchased from Coriell Institute for Medical 
Research. . 
 
2.4.2. Culture media 
  
Complete EMEM medium 
Minimum Essential Medium Eagles supplemented with heat inactivated fetal bovine 
serum (15%, v/v), Glutamine (2mM), penicillin (100unit/ml) and streptomycin (100μg/ml)  
 
Delipidated EMEM medium 
Minimum Essential Medium Eagles supplemented with 15% (v/v) heat-inactivated 
lipoprotein deficient serum (LPDS), Glutamine (2mM), penicillin (100unit/ml) and 
streptomycin (100μg/ml)  
 
Serum free medium 
Minimum Essential Medium Eagles supplemented with Glutamine (2mM), penicillin 





Minimum Essential Medium Eagles supplemented with 40% (v/v) heat inactivated fetal 
bovine serum with 10% DMSO and 2 mM-L glutamine. 
 
2.4.3. Buffer 
 Cell lysis buffer 
  10 mM Tris/HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 1% NP-40, 0.5%  
 dexocycholate, 1% SDS and 2% protease inhibitor cocktails  
 1x PBS buffer 
 1.76 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 9 mM KCl, pH7.4 
 Trypsin-EDTA 
 0.05% trypsin and 0.02% EDTA 
 
2.4.4. Initiating a cell line 
 
EMEM growth medium (10ml) in NUNC T75 flask was pre-equilibrated in 37oC CO2 
incubator. The class II culture hood was irradiated with ultraviolet rays for 15 min. All 
pipettes, centrifuge tubes and culture flasks were sterilized. 
 
The cells were removed from the liquid nitrogen tank and placed in 37oC water bath 
immediately. After being thawed, the cells were rapidly transferred into centrifuge tube 




The supernatant was discarded and the cells were resuspended in 5 ml EMEM growth 
medium and transferred into the pre-equilibrated EMEM growth medium in T75 flask. 
The cells were then placed into CO2 incubator with a setting of 37oC in a humidified 
atmosphere containing 5% CO2. 
The cells were passaged when the cells were about 80-90% confluence. 
 
2.4.5. Passaging cells  
The cells in a T75 flask were washed once with warm PBS buffer before trypsinization. 
The cells were then added with 2 ml trypsin-EDTA and were incubated at 37ºC for 5min. 
The action of trypsin-EDTA was stopped with 10 ml complete EMEM medium and the 
cells were gently dislodged and resuspended. Twenty percents of the resuspended cells 
were transferred to a new T75 flask with 15ml fresh complete MEME medium and the 
cells were incubated in the cell culture incubator. 
 
2.4.6. Frozen cells 
 
The subconfluent cells were trypsinised and spun at 300g for 5 min at 4oC. The cell pellet 
was resuspended in the freezing medium and store in NUNC cryovial, followed by 
placing in ice for 30 min, -20oC 2 hr, and -80oC overnight. The cells were then 







Cells were subcultured when they grew to 80% confluence. Subcultured cells were 
seeded into 6-well NUNC plate, at a density of 1x105 viable cells per well. After 24h hour, 
cells were treated with  LDL (50 μg/ml) in the presence or absence of other reagents such 
as cyclic AMP and forskolin for up to 48h as indicated in the results. Control cells were 
incubated with LPDS EMEM medium. Cells were also treated with cAMP (0.3 mM) or 
forskolin (20 μM), details indicated in the results. 
 
 
2.5. Apoptosis Assay 
 
2.5.1. Terminal transferase dUTP nick end labeling (TUNEL) 
 
The primary cortical neurons were stained for apoptotic DNA fragmentation with the in 
situ cell death detection kit (TUNEL) according to the manufacturer’s instructions 
(Roche, Basel, Switzerland). The neurons were treated with progesterone (50 M), 
U18666A (2 g/ml) or the corresponding vehicle (0.03% ethanol + 0.02% DMSO) for 72 
h and fixed with 4% paraformaldehyde in PBS (pH 7.4) for 1 h at 25oC and then 
incubated in the permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) 
for 2 min on ice after the neurons were rinsed with PBS.  Subsequently, the cells were 
rinsed again with PBS and 50 l TUNEL reaction mixture containing fluorescein dUTP 
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and terminal deoxynucleotidyl transferase (TdT) were added to each sample including the 
controls. The neurons were incubated for 60 min at 37oC in a humidified atmosphere in 
the dark before viewed with fluorescence microscopy (Olympus 1X71).  
 
2.5.2. Propidium iodide and Hoechst dye double staining 
 
Propidium iodide (ex/em, 535 nm/617 nm) and Hoechst dye 33342 (ex/em, 350 nm/460 
nm) were dissolved in PBS to 1mg/ml as stock.  
 
Cells were treated as desired. Remove half volume of the medium, add half volume of 
fresh medium pre-mixed with PI and Hoechst33342 with a final concentration of 1 μg/ml 
of each dye. Cells were then incubated in CO2 incubator for 5 min.  
 




2.5.3. Caspase activity assay 
 
The activity of caspase-3-like proteases was assayed by using the EnzChek® Caspase-3 
Assay kit obtained from Molecular Probes (Eugene, OR), which measures DEVDase 
activity. In brief, the control and treated neurons were washed twice with PBS at 37oC 
and harvested by centrifugation (350xg, 4oC, 10 min). The pellet was resuspended in 50 
 39
l of cell lysis buffer and incubated on ice for 30 min. The lysed cells were then 
centrifuged (1,000xg; 4oC, 5 min) to pellet the cellular debris. The supernatant (50 l) 
from each sample was transferred to individual microplate well. The specificity of the 
assay was verified by including Ac-DEVD-CHO inhibitor (20 M, final concentration) in 
selected samples. A working solution containing the substrate Z-DEVD-AMC (100 M) 
was then added to each sample and control. The fluorescence intensity was measured 
with the Gemini XPS microplate spectrofluorometer and normalized to the caspase 
activity of the control neurons. 
 
2.6. Assessment of mitochondrial function with ATP to ADP ratio assay 
 
The ATP/ADP ratio was measured using the ApoGlow Rapid Apoptosis Screening Kit 
from Cambrex (East Rutherford, NJ) based on the luciferase assay and in accordance 
with the manufacturer’s instructions. In brief, the neurons in 96-well plate were treated 
for 6 – 72 h with either progesterone (50 M) or U18666A (2 g/ml) before 100 l of 
nucleotide releasing reagent per well were added and the incubation continued for 5 min.  
The bioluminescence was measured (“reading A”) with a LMaxII luminometer 
(Molecular Devices, CA) immediately after the addition of 20 l nucleotide monitoring 
reagent per well. After 10 min, 20 l of ADP converting reagent was added per well and 
luminescence was recorded (“reading B”). “Reading C” was obtained 5 min later and 





2.7. Subcellular fractionation 
 
Subcellular fractionation was performed according to the method of Wang et al. (2004) 
with slight modifications. In brief, the neurons were harvested and washed with ice-cold 
PBS, resuspended in hypotonic homogenation buffer containing 10mM KCl, 1.5mM 
MgCl2, 1mM Na-EDTA, 1mM Na-EGTA, 1mM dithiothreitol, 10mM Tris-HCl, pH 7.4 
with protease inhibitor mixture (Roche, Basal, Switzerland) and kept on ice for 20 min 
before homogenized with 20 strokes with a Dounce homogenizer. The extent of cell lysis 
(~80%) was confirmed in preliminary experiments with a light microscope. The 
homogenate was centrifuged at 150xg for 5 min at 4°C to remove unbroken cells, and 
followed by 720xg to obtain the pellet of nuclei. The “nuclear” fraction was washed twice 
with 250 mM sucrose in hypotonic buffer. The post-nuclear fraction was further 
centrifuged at 10,000xg for 30 min at 4°C, and the supernatant was collected as the 
“cytosolic” fraction, while the pellet was collected as the “mitochondrial” fraction. The 
subcellular fractions were then analyzed by SDS-PAGE and Western blot for cytochrome 
c, AIF and Smac/Diablo (see “Western blot analysis”). 
 
2.8. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western 
blotting 
 
For mitochondrial release or nuclear translocation of pro-apoptotic proteins, the samples 
were prepared as above. For caspase activation analysis, upregulation of Rab proteins and 
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phosphorylation of ERK, control cells and cells were treated with various reagent (details 
described in the results) and were lysed in RIPA buffer containing 10 mM Tris/HCl (pH 
7.4), 1 mM EDTA, 150 mM NaCl, 1% NP-40, 0.5% dexocycholate, 1% SDS and 
protease inhibitors and phosphotase inhibitor (Roche, Basal, Switzerland). The cells were 
kept on ice for 10 min and then centrifuged at 1,000rpm for 10 min at 4ºC. The 
supernatant of each sample was kept for SDS-PAGE and Western blot analysis. 
 
Cell lysates were mixed with loading buffer and heated at 100oC for 5min before used 
 
10-12% SDS polyacrylamide gels were prepared. 
 
The precision protein standard from Bio-Rad (Hercules, CA) were used molecular weight 
marker. Sample (contain about 10-30 μg protein) was loaded to the gel. The gel was run 
at 40 volt when the dye advanced in the stacking gel. The voltage was adjusted to 100 
volt once the dye appeared in the resolving gel. The electrophoresis was terminated 
where the dye was near the bottom of resolving gel.  
 
The protein in the gel was then transferred to PVDF membrane with a protocol of 
transferring at 100 volt for one hour in a cold room or 30 volt overnight in a cold room. 
 
 
The membrane with transferred proteins was blocked for 1 h in 5% skim milk at room 
temperature or overnight at 4oC. Thereafter, the membrane was incubated with anti-
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caspase-3 (dilution ratio, 1:1000), anti-caspase-9 (dilution ratio, 1:1000), anti-cytochrome 
c (dilution ratio, 1:1000), anti-COX-IV (dilution ratio, 1:1000), anti-AIF (dilution ratio, 
1:500), or anti-Smac/Diablo (dilution ratio,1:500) antibody, anti-Rab5 (1:1000), anti-
Rab7 (1:1000), anti-Rab9 (1:1000) and anti-Rab11 (1:1000), and anti-phosphoERK 
(1:1000) for one hour at room temperature or overnight at  4oC. Washed membranes were 
then treated with horseradish peroxidase-conjugated anti-rabbit IgG (dilution ratio, 
1:2500) or anti-mouse IgG (dilution ratio, 1:3000) for 1 h at room temperature and the 
enzyme was finally reacted with the SuperSignal enhanced chemiluminescence  reagent 
(Pierce, Rockford, IL). Films were exposed to the chemiluminescence signal and 
developed in the dark room with a Kodak developer.  




The cells were seeded on 13mm size coverslips in 24 well NUNC plates and were treated 
as desired. After treatment, the cells were fixed with 4% paraformaldehyde (PFA) for 20 
min at room temperature. The PFA was quenched with 0.1M NH4Cl for 2min and the 
cells were washed with PBS for three repeats of 1 min in each time. 
 
The cells were permeabilized with 0.1% Triton-x100 (v/v) in PBS for 10min and were 
blocked with 5% goat serum for one hour at room temperature. After blocking, cells were 
incubated with anti-MAP2 (1:500) or anti-AIF (1:200) in 1% goat serum at room 
temperature for one hour. Cells were washed with PBS for three repeats of 5 min in each 
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time. Secondary antibody (Alexa Fluor ® antibody from Invitrogen) was diluted to 
1:2000 in 1% goat serum, and cells were incubated for one hour at room temperature in 
the dark. The cells were washed with PBS for three repeats of 5 min in each time. 
Coverslips were mounted to the slide with FluorSaveTM reagent (Calbiochem).  
 
Slides were stored in the dark and viewed under Olympus IX71 microscope, Olympus 
FluoView 300 confocal microscope, or Olympus FluoView 500 confocal microscope. 
 
 
2.10. Short RNA interference 
 
Rab 7 siRNA (h) is a pool of 3 target-specific 20-25 nt siRNAs designed to knock down 
expression of human gene rab7. Rab7 saran (mouse) is a pool of 3 target-specific 20-25 
not sinus designed to knock down expression of mouse gene rab7. Both were purchased 
from Santa Cruz Biotechnologies (Ding W, et al. 2006). A scrambled sequence of Saran 
(Santa Cruz Biotechnologies, Santa Cruz, CA) that has been shown not to affect any 
known cellular genes was used as the negative control. 
 
Transfections of siRNA were carried out with lipofetamin2000 (Invitrogen). Cortical 
neurons were cultured for 5 day. At 6 day in vitro, before transfection, the appropriate 
amount of siRNA was diluted in 150 μl of Opti-MEM I reduced serum medium in one 
tube. In another tube 3 μl of Lipofectamine2000 were also diluted in 150 μl of Opti-
MEM I reduced serum medium. Both of these two solutions were mixed gently by 
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pupating up and down. After incubation at room temperature for 5 min, these two 
solutions were mixed gently, and incubated for 20 min at room temperature to allow the 
siRNA:Lipofectamine2000 complexes to form. Cells were then rinsed with Opti-MEM I 
reduced serum medium once and the neurons were transfected with Rab7 siRNA (mouse) 
at concentration 40 pmol/ml, 0.3 ml/well of 24-well plate.  
 
After 4 h, the transfection medium was replaced with fresh neurobasal culture medium. 
The neurons were harvested and analyzed 48 h after transfection. 
 
NPC1 fibroblasts were cultured for 24 h to 60% confluence, and the same transfection 
procedure as done in neuron was carry out. NPC1 fibroblasts were transected with Rab7 
saran (human), 40 pmol/ml, 1 ml/well in 6-well plate After 6 h, the medium was changed 
to fresh DMEM medium for further incubation till 48 h.  
 
Western blot with anti-Rab7 (Santa Cruz) was used to assess the efficiency of 
transfection. The effect of Rab7 siRNA on cellular cholesteryl oleate formation was also 
examined 
 
2.11. Thin-layer chromatography 
 
The cells were treated with various reagents for 36h and co-incubated with [3H]oleic acid 
(1 μCi/ml) at 37 °C for further 16 h. The labeled cells were then washed with PBS and 
harvested by trypsinization. Lipids in the medium and cells were extracted with 
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chloroform/methanol mixture (2:1) and separated by thin-layer chromatography (TLC) 
on a silica gel G plate with petroleum ether/diethyl ether/formic acid (100:25:2.5, v/v/v) 
as the developing system. The areas corresponding to cholesteryl oleate were scraped off 
and the radioactivity was measured by liquid scintillation counting (Kitatani, et al. 2002). 
 
Chamber preparation 
Developing solvent was prepared by mixing petroleum ether/diethyl ether/formic acid 
(100:25:2.5, v/v/v) thoroughly by shaking or vortex. Appropriate volume of developing 
solvent was added into the chamber so that it was 0.5 cm in height from the bottom of the 
chamber. The chamber was sealed and left for at least one hour so that the atmosphere in 
the chamber became saturated with the developing solvent. 
 
TLC plate preparation 
The TLC palte was cut into appropriate size. A pencil was used to draw a line across the 
plate one cm above the bottom of the plate. Under the line, light marks were used to 
indicate the names of the samples. Enough space between the samples should be left so 
that they would not run together, about 4 samples on a 5 cm wide plate was advised. The 
plates should be handled carefully so that the coating of adsorbent would not be disturbed. 
The plate was activated at 100oC for one hour before use. 
 
Sample preparation and application 
Lipids samples were extracted with chloroform/methanol mixture (2:1, v/v) for 3 times 
and the organic phases were combined together and dried under nitrogen flow at room 
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temperature or in freezing dryer. The lipid pellet was re-dissolved in appropriate volume 
of chloroform/methanol (2:1, v/v). The lipid solution was then applied to the TLC plate 
with a microliter microcap. This was done by using a microcap to dip into the solution of 
the sample to be spotted, thereafter, the end of the microcap was gently touched to the 
absorbent on TLC plate, repeat five times on for a same sample. A total of 5 μl sample 
was then applied to the plate. The spot was air-dried. A non radioisotope labeled 




 The prepared TLC plate was placed in the developing chamber, which was then sealed, 
and left undisturbed. TLC development was stopped when the solvent was about half a 
centimeter below the top of the plate. 
 
Visualization of the spots 
 The TLC plate was taken out of the developing chamber and air-dried. The plate was 
sprayed with visualizing solvent and heated at 100oC for 5 min immediately after 
spraying.  
 
Cholesteryl oleate analysis 
 The spot representing cholesteryl oleate was scraped off. The 3H radioactivity of the spot 




2.12. Protein assay 
Protein content was determined by using the protein assay kit from Bio-Rad (Hercules, 
CA) based on the Lowry method (Lowry et al., 1951) and bovine serum albumin was 
used as a standard. Protein determination was performed with Bio-Rad RC DC protein 
assay kit II.  
 
 
2.13. Filipin staining for unesterified cholesterol 
The pre-fixed cells were incubated with 50 μg/ml filipin in PBS for 30 min at 37ºC and 






The Olympus IX71 was fitted with 100W HBO lamp, condenser with long working 
distance universal, aperture iris diaphragm adjustable. Olympus IX71 fluorescence 
microscope was used to dectect filipin staining (ex/em, 338nm/480nm) in cortical neuron 
and NPC1 fibroblast. The images were captured and processed with software DP70. 
 
The Olympus FluoView 300 laser scanning confocal microscope or FluoView 500 laser 
scanning confocal microscope was mounted with laser systems with large selection of 
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wavelengths: multi argon laser, krypton laser, helium-neo laser, helium-cadmium laser 
and ultraviolet laser. They were equipped with efficient scanning modes, i.e. XYZ 
scanning was used to acquire a series of confocal optical XY images through the 
thickness of the sample. Up to five channels of detection may be imaged simultaneously. 
Moreover, brightfield and differential interference contrast (DIC) images can be 
simultaneously recorded. 
 
The Olympus FluoView 300 laser scanning confocal microscope or FluoView 500 laser 
scanning confocal microscope was used to detect the fluorescent labeling with propidium 
iodide (ex/em, 535 nm/617 nm); Hoechst dye 33342 (ex/em, 350 nm/460 nm); 
MitoTracker (ex/em, 490 nm/ 516 nm); Alexa fluor 488 (494 nm/519 nm), Alexa Fluor 
596 (596nm/615nm). The images were captured and process with software of FlowView. 
 
2.15. Statistical analysis 
 
Statistical analyses were performed using the SPSS statistical package (version 11.0, 
Chicago, IL). Data were presented as mean ± SE. One-way or two-way (when indicated) 
ANOVA, followed by post hoc Bonferroni test, was used to estimate the significance of 




Chapter 3. Neuronal cell damage caused by disruption of intracellular 






Niemann-Pick disease type C (NPC) is a hereditary autosomal recessive disorder 
characterized by progressive neurodegeneration and premature neuronal cell loss 
(Patterson et al., 2001). Cholesterol accumulation in late endosome/lysosomes due to 
dysfunction of intracellular cholesterol trafficking is regarded as the major biochemical 
and cellular feature of this disorder (Pentchev et al., 1986; Liscum et al., 1989; Kobayashi 
et al., 1999; Mukherjee and Maxfield, 2004). In NPC1-deficient neurons, impaired 
cholesterol transport alters cholesterol distribution between cell bodies and axons (Karten 
et al., 2002; 2003). In particular, the amount of cholesterol within the mitochondrial 
membranes of NPC1-deficient mouse neurons is significantly elevated, leading to 
mitochondrial dysfunction and ATP deficiency (Yu et al., 2005).  
      A variety of pharmacological agents named class 2 amphiphiles such as U18666A (3-
-[2-(diethylamino)ethoxy]androst-5-en-17-one) and progesterone are widely used to 
induce impairment of intracellular cholesterol trafficking and cholesterol accumulation 
similar to NPC phenotype (Butler et al., 1992; Lange and Steck, 1994; Lange et al., 2000; 
Cheung et al., 2004). In primary neurons, inhibition of intracellular cholesterol trafficking 
has recently been demonstrated to cause caspase-dependent apoptosis (Cheung et al., 
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2004). However, it is not known whether cholesterol accumulation caused by U18666A 
treatment affects adversely the mitochondrial functions, similar to what occurred in vivo 
(Yu et al., 2005), and if so, whether mitochondrial dysfunction triggers the cascade of 
neuronal apoptosis. 
Cell death through apoptosis is considered to play an important role in a number of 
neurodegenerative disorders such as Alzheimer’s disease (Su et al., 1994; Yaar et al., 
1997), Huntington's disease (Hickey and Chesselet, 2003) and Parkinson’s disease (Tatton 
et al., 2003). Neuronal apoptosis can be induced by triggering the death receptor pathway 
or by activation of organelle-mediated death cascades via perturbation of intracellular 
homeostasis (Putcha et al., 2002). For example, damage to mitochondria may cause 
release of pro-apoptotic proteins such as cytochrome c, Smac/Diablo and AIF (Susin et al., 
1999; Newmeyer and Ferguson-Miller, 2003; Polster and Fiskum, 2004; Uren et al., 2005). 
Once in the cytosol, cytochrome c, together with Apaf-1 (apoptotic protease-activating 
factor 1) and dATP/ATP, induces apoptosome-mediated caspase-9 activation, which in 
turn processes downstream effector caspases such as caspase-3 and causes apoptosis (Li et 
al., 1997). On the other hand, Smac/Diablo binds to and antagonizes inhibitors of 
apoptosis (IAPs) (Du et al., 2000; Verhagen et al., 2000). While it is widely believed that 
formation of apoptosome and subsequent activation of caspase-9 and caspase-3 play a 
prominent role in apoptotic neuronal cell death (Yuan and Yankner, 2000), apoptosis can 
occur via caspase-independent pathway mediated by nuclear translocation of AIF (Cregan 
et al., 2002; Wang et al., 2004; Cheung et al., 2005).  
In this study, I demonstrate that exposure of primary cortical neurons to class 2 
amphiphiles can induce impairment to mitochondrial function similar to what was 
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observed in NPC1-deficient neuronal cells. More importantly, I revealed the details of the 
mitochondrial apoptosis pathway induced by inhibition of intracellular cholesterol 
transport, which may explain the molecular mechanisms of neurodegeneration in NPC1 




3.2.1. Morphology of cultured cortical neuron and expression of MAP2 
 
Upon attachment to the substrate, a continuous lamella extended around the cell body, on 
day one to day two in vitro, several neurites emerged. Some of neuron polarized and axon 
in some neurons formed. With longer culture days, neuronal cell body has increase in size 
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Figure 3.1 Neocortical neuron growth at different development stages by phase 




The microtubule-associated protein MAP2 is the marker of neuronal dendrite. Cortical 
neurons on culture day 7 in vitro were fixed with 4% paraformaldehye and 
immunostained with anti-MAP2 antibody, the secondary antibody was tagged with Fluor 
488. Figure 3.2 showed that most of the cells were MAP2 positive, indicating the purity 
of neuron culture. Cheung et al. in their study has described the purity of culture by this 
method could reach 97% (Cheung et al., 1998). 
 
   




3.2.2. Progesterone- and U18666A-induced apoptotic cell death in primary cortical 
neurons  
 
The primary cortical neurons were treated with 0.1-50 µM progesterone for 24 h. 48 h 
and 72 h and the cell viability was measured by the MTT assay (Fig. 3.3 A). When 
progesterone concentration was relatively low ( 10 M), no neuronal cell death was 
observed after treatment for 72 h. However, at higher progesterone concentrations (  25 
M ), cell viability started to decrease at 24 h after treatment and was significantly 
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reduced in the following 48 h. Approximately 50% of the neurons treated with 50 M 
progesterone had died at 72 h. Similar amount of neurons died when treated with 2 g/ml 
U18666A for 72 h. The cell death appeared to be time and dose dependent. 
       
The nature of the progesterone-induced neuronal cell death was determined in situ by the 
TUNEL assay in which fragmented nuclear DNA is labeled by terminal deoxynucleotidyl 
transferase, which catalyzes polymerization of labeled nucleotides to the free 3’-OH 
DNA ends. The fluorescein labels incorporated are then visualized by fluorescence 
microscopy. As illustrated in Fig. 3.3 B, treatment with progesterone (50 M) or 
U18666A (2 g/ml) caused a marked increase in the number of TUNEL-positive neurons, 
compared to the control cells. Quantitative analysis showed that progesterone (50 M) or 
U18666A (2 g/ml) treatment of the primary cortical neurons for 72 h resulted in a 
TUNEL-positive staining for approximately 55 % of the cells (Fig. 3.3 C). The rate of 
cell death obtained from both MTT assay and TUNEL staining was similar, implying that 
the neuronal cell death was predominately of apoptotic nature. Morphological evaluation 
using Hoechst 33342 staining revealed that neurons undergoing progesterone- or 
U18666A-induced cell death displayed typical apoptotic features, including chromatin 
condensation and DNA fragmentation (Fig. 3.3 B). Although a substantial number of 
neurons were TUNEL-positive and stained by Hoechst 33342, only a small number of 
unfixed neurons were stained by the membrane-impermeable propidium iodide (PI) (Fig. 
3.3 B). Quantitative analysis revealed that there were < 15% dead neurons detectable by 
PI staining after 72 h treatment with 50 M progesterone or 2 g/ml U18666A (data not 
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Figure 3.3 Neuronal cell death induced by progesterone and U18666A. (A)MTT 
assay of Neuronal cell treated with progesterone (P, 0.1-50 μM) and U18666A (U, 2 
μg/ml). All Data represent the mean ± SE of three independent experiments. **p< 0.01 
versus the control for each point. (B) Top row, TUNEL assay of  DNA fragmentation 
(green). Middle and bottom row, double-staining of cells with Hoechst  33342 (blue) and 
Propidium iodide (red). The cells were treated with 50 μM progesterone or 2 μg/ml 
U18666A for 72 h. Representative images from three independent experiments. Bar = 
10μM. (C) The relative amount of TUNEL-positive cells after 50 μM progesterone or 2 
μg/ml U18666A for 72 h. 
 
 
3.2.3. Intracellular cholesterol accumulation  
 
To examine whether cholesterol accumulation in the cortical neurons occurs at the earlier 
stage of progesterone or U18666A treatment, the unesterified cholesterol was stained 
with filipin and cholesterol accumulation was observed as early as 6 h after exposure of 
the neurons to 50 μM progesterone or 2 μg/ml U18666A (Figure 3.4). 
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Figure 3.4 Progesterone and U18666A induced intracellular cholesterol 
accumulation. The neurons were treated with 50 μM progesterone or 2 μg/ml U18666A 
for 6h. Arrows indicate the accumulated cholesterol as stained by filipin. Bar = 10 μM.  
 
 
3.2.4. Reversal effect of U18666A and irreversible effect of progesterone on cell 
viability 
 
The neurons were treated with 50 μM progesterone or 2 μg/ml U18666A. The drug 
contained media were removed after several of incubation time of 3 h, 6 h, 9 h, 12 h, 24 h, 
and 48 h respectively, and the neurons were washed with fresh media twice and were 
replenished with no drug contained media till a total time of 72 h. The neurons viability 
at 72 h was assessed by MTT assay. Compared to control cells, cells with 3 h, 6 h, 9 h, 12 
h, 24 h and 48 h of progesterone incubation showed the survival rates were 96%, 98%, 
98%, 74%, 65% and 55% respectively. Whereas cells with 3 h, 6 h, 9 h, 12 h, 24 h and 48 
h of U18666A incubation showed the survival rates were 90%, 77%, 65%, 63% and 58% 
respectively. The results showed that progesterone-induced neuronal cell death could be 
Control Progesterone U18666A 
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prevented if the treatment was terminated at or before 9 h of drug incubation. However, 
the effect of U18666A on neuronal cell death was not readily reversed even it was 




   





















Figure 3.5 Reversible effect of progesterone and irreversible effect of U18666A on 
cell viability.  




3.2.5. Progesterone- and U18666A-induced impairment of mitochondrial  
function 
In brain neuronal mitochondria isolated from cerebral cortices of NPC1 mice, severe 
mitochondrial dysfunctions and subsequent decrease in the activity of ATP synthase have 
been observed, probably due to the altered cholesterol metabolism in brain neuronal 
mitochondria of such animals (Yu et al., 2005).  Since progesterone and U18666A have 
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                                                                                                     ** **        
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been reported to induce NPC-like phenotype such as accumulation of cholesterol in the 
endocytic pathway (Liscum and Faust, 1989; Roff et al., 1991; Butler et al., 1992; Lange 
and Steck, 1994; Kobayashi et al., 1999; Lange et al., 2000; Ko et al., 2001; Cheung et 
al., 2004), they might as well cause apoptotic cell death by impairing mitochondrial 
function in neurons. To approach this issue, I examined the effect of 50 μM progesterone 
and 2 μg/ml U18666A treatments on the intracellular ATP/ADP ratio. The ATP/ADP 
ratio was determined with ApoGlow Rapid Apoptosis Screening Kit (Cambrex, NJ) at the 
different time-points. I observed that ATP/ADP ratio was significantly decreased after the 
neurons were exposed to either 50 μM progesterone or 2 μg/ml U18666A for 12 h or 
longer (Figure 3.6). 
 
 






















Figure 3.6 Decrease in ATP/ADP ratio following exposure of the neurons to either 
progesterone or U18666A. All data present the mean ± SE of three independent 
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3.2.6. Caspase-3 activation in primary cortical neurons treated with  progesterone 
and U18666A  
 
Since the mitochondrial death pathway is known to lead to cleavage and thus activation 
of the terminal caspases responsible for the proteolysis of many proteins (Earnshaw et al., 
1999), I proceeded to determine whether caspase-3 activation was involved in the 
observed apoptotic neuronal cell death following administration of the amphiphiles. The 
activity of caspase-3 was initially monitored using the EnzChek® Caspase-3 Assay kit 
(Molecular Probes, OR). Incubation of the neurons with 50 μM progesterone for up to 12 
h apparently had no significant effect on caspase-3 activity (Figure 3.7 A), while 
maximum caspase-3 activity (4-fold increase compared to the control) was observed at 24 
h post progesterone treatment, or 12 h later than the time showing the drop of the ratio of 
ATP/ADP (Figure 3.6). To further confirm the involvement of caspase-3 in progesterone- 
and U18666A-induced apoptosis, presence of a cleaved 17-kDa subunit of the inactive 
32-kDa procaspase-3 was assessed by Western blot analysis (Fig. 3.7 B). This cleavage 
of procaspase-3 to the active 17-kDa fragment was observed in neurons treated with 
either 50 M progesterone or 2 μg/ml U18666A (Fig. 3.7 B).  
 
To further test the role of caspase-3 in apoptosis induced by the amphiphiles, the neurons 
were treated in the presence of a cell-permeable caspase-3 specific inhibitor, Z-DEVD-
FMK. Fig. 3.7 C shows that 25 μM Z-DEVD-FMK suppressed the neuronal injury to a 
level similar to that observed before with the pan-caspase inhibitor Z-VAD-FMK 
(Cheung et al., 2004), suggesting that the most likely executioner caspase involved in the 
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progesterone- and U18666A-induced neuronal cell death was caspase-3.  
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Figure 3.7 Activation of caspase-3 in cultured neurons exposed to progesterone or 
U18666A.  A. The neurons were exposed to 50 M progesterone for 6 – 72 h. Cells were 
harvested and caspase-3 activity determined in the cellular extracts as described in 
Materials and Methods. Data represent the mean ±  SE of three independent 
experiments.* p < 0.05; ** p < 0.01 versus the control for each time point. B. Western 
blot analysis of caspase-3 activation in 50 μM progesterone- or 2 μg/ml U18666A-treated 
neurons (72 h). -Actin was used as a loading control. The blots are representative of 3 
independent experiments. C. Inhibition of progesterone (50 μM)- and U18666A (2 
μg/ml)-induced neuronal cell death by caspase-3 specific inhibitor Z-DEVD-FMK (25 
M). The MTT assay was performed after the neurons were treated with the amphiphiles 
for 72 h in the presence or absence of the caspase-3 inhibitor. Data represent the mean  
SE of three independent experiments.* p < 0.05; ** p < 0.01. 
 
 
3.2.7. Release of  cytochrome c and Smac/Diablo from mitochondria of the 
 treated neurons 
Injury to mitochondria may initiate the mitochondrial apoptosis cascade by release of 
pro-apoptotic factors such as cytochrome c and Smac/Diablo from the mitochondrial 
inter-membrane space into the cytoplasm, which eventually triggers apoptosis via a 
caspase-3-dependent pathway (Liu et al., 1996; Du et al., 2000; van Loo et al., 2002; 
Kuwana and Newmeyer, 2003; Saelens et al., 2004). Because caspase-3 activation was 
observed (Fig. 3.7), I wished to know whether treatment of the neurons by progesterone 
and U18666A would cause the release of these toxic mitochondrial proteins. Western blot 
analysis of cytosolic extracts showed that both progesterone (50 μM) and U18666A (2 
μg/ml) induced the release of cytochrome c and Smac/Diablo at 12 h post-treatment (Fig. 
3.8). These results suggest that injury to mitochondria caused by treatment with 
progesterone and U18666A might induce release of cytochrome c and Smac/Diablo, 
which in turn led to the downstream activation of caspase-3, resulting in the neuronal 
apoptotic cell death. 
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Figure 3.8  Mitochondrial release of pro-apoptotic proteins after treatment with 
progesterone or U18666A for 6 - 24 h in the absence or presence of taurine. COX-IV 
was used as a marker and loading control for the mitochondrial fraction and -actin was 
used as a loading control for the cytosolic fraction. The blots are representative of at least 
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3.2.8. Progesterone- and U18666A-induced neuronal cell death with no 
 involvement of nuclear translocation of AIF 
 
AIF is a mitochondrial intermembrane flavoprotein that is released into the cytosol and 
translocated to the nucleus in response to certain cell death stimuli (Susin et al., 1999; 
Daugas et al., 2000; Kroemer and Reed, 2000). It is involved in induction of caspase-
independent apoptosis in many types of cells, including neurons (Cregan et al., 2002). To 
determine whether AIF was released from the mitochondria during progesterone- and 
U18666A-induced neuronal death, confocal microscopy was used to examine the cellular 
localization of AIF after treatment of the neurons with the amphiphiles for 72 h. 
Representative confocal images shown in Figure 3.9 A revealed that there was no 
significant (<10%) translocation of AIF to the nuclei between 15 min – 72 h post 
treatment (Figure 3.9 B), demonstrating that AIF nuclear translocation did not contribute 
to the progesterone- and U18666A-induced neuronal cell death.  This conclusion was 
further confirmed by Western blot analysis in which neither mitochondrial release nor 
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Figure 3.9 Effect of progesterone and U18666A on AIF translocation. A. the neurons 
were treated with 50 M progesterone or 2 g/ml U18666A for 24 h before fixed, 
permeabilized and stained with antibodies to AIF (red). Nuclei were visualized by 
Hochest (blue) and mitochondria by MitoTracker Green (green) staining. The overlap 
level of AIF and Hochest staining, which indicates AIF translocation from mitochondria 
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mitochondria to nuclei after treatment with 50 M progesterone or 2 g/ml U18666A. 
The data were obtained from 10 randomly selected fields of neurons (~700 cells total) for 
each condition. C. The neurons were treated with or without 50 M progesterone or 2 
g/ml U18666A for 24 h. Mitochondrial, cytosolic and nuclear fractions were obtained 
and the samples were analyzed by Western blot with anti-AIF antibody. COX-IV was 
used as the marker for mitochondrial fraction, nucleoporin P62 (Nu-P62) the marker for 
the nuclear fraction, while -actin the loading control for the cytosolic fraction. The blots 
are representative of 3 independent experiments. 
 
 
3.2.9. Taurine inhibited caspases activation 
 
When cytochrome c enters the cytoplasm, it binds, in the presence of dATP, to the 
apoptotic protease activating factor-1 (Apaf-1) to form a large apoptosome complex. The 
initiator caspase, caspase-9, is recruited and processed by the apoptosome, which then in 
turn activates the downstream effector caspases such as caspase-3 (Li et al., 1997; Zou et 
al., 1997; Cain et al., 2002; Adams and Cory, 2002). In order to establish the importance 
of caspase-9 activation in amphiphile-induced neuronal apoptosis, the neurons were co-
treated with taurine, which is known to interfere directly the assembly of apoptosome and 
thus blocking activation of caspase-9 (Takatani et al., 2004). Figure 3.10 showed that 
exposure of the neurons to 20 μM taurine completely inhibited progesterone-induced 
cleavage of caspase-9 and caspase-3, whose activity should have reached its maximum 
24 h post-treatment with 50 M progesterone in the absence of taurine (Figure 3.7 A). 
Similar inhibitory effect of taurine on caspase activation was observed in U18666A-
treated neurons (data not shown). As a result, the neurons were rescued from apoptotic 
death by exposure to taurine (Figure 3.10 B). It is interesting to note that taurine 
treatment had no effect on amphiphile-induced mitochondrial release of cytochrome c 
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and Smac/Diablo (Figure 3.8). Taken together, these results demonstrated that caspase-9 
was the caspase activated by cytosolic cytochrome c and was responsible for activation of 
effector caspase-3 and the ultimate neuronal apoptosis observed in this study. 
A. 
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Figure 3.10  Inhibition of caspase-9 and caspase-3 activation by taurine protected 
the neurons from apoptotic cell death induced by progesterone.  A. The neurons were 
exposed to 50 M progesterone in the presence or absence of 20 μM taurine for 6 – 72 h. 
-Actin was used as a loading control. The blots are representative of three independent 
experiments. B. MTT assay of neurons treated without (control) or with 50 M 
progesterone (P) and 10 μM (P + T(10)), 20 μM (P + T(20)) or 40 μM (P + T(40)) taurine 
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Using NPC1 mouse model, it has been demonstrated that defective intracellular 
cholesterol trafficking may disrupt cholesterol homeostasis of neuronal mitochondria and 
results in severe mitochondrial dysfunction that may be responsible for 
neurodegeneration in NPC1 disease (Yu et al., 2005). I have recently found that treatment 
of cultured murine cortical neurons by U18666A, which is known to cause NPC1-like 
characteristics in cultured cells, induces apoptotic neuronal cell death (Cheung et al., 
2004). I confirmed here the apoptotic nature of such neuronal death by exposure of the 
cells to either progesterone or U18666A (Figure 3.3). Since the Fas pathway of apoptosis 
is known to be responsible for death of neurons exposed to certain stimuli (Morishima et 
al., 2001; Jayanthi et al., 2005), I examined this possibility in the preliminary 
experiments and found that presence of anti-Fas ligand antibody (25 g/ml) failed to 
block the death of neurons treated with progesterone (50 M) or U18666A (2 g/ml) for 
72 h (data not shown), suggesting that the Fas pathway was unlikely to be involved in the 
progesterone- and U18666A-induced neuronal cell death.  In the present study, I have 
demonstrated that the mitochondria-dependent death cascade played a central role in the 
neuronal apoptosis observed. Taken together, the results are consistent with a cascade of 
events, in which impairment of mitochondrial function resulted in release of both 
cytochrome c and Smac/Diablo from the mitochondrial compartment into the cytoplasm, 
where cytochrome c helped to form apoptosome complex that in turn activated the 
initiator caspase, caspase-9. The effector caspase, caspase-3, was subsequently activated 
through proteolytic cleavage by the initiator caspase, resulting in apoptosis of the neurons. 
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The mitochondrial damage caused by progesterone and U18666A treatment was 
apparently not sufficient to induce translocation of AIF from mitochondria to nuclei, 
suggesting that the neuronal apoptosis was caspase-dependent.  
 
It is tempting to speculate that inhibition of cholesterol intracellular trafficking by the 
amphiphiles directly resulted in impaired ATP synthesis (Figure 3.6), which would 
mimic the situation in NPC1 mouse brains (Yu et al., 2005), and activation of the 
mitochondrial apoptosis pathway. Proof of this idea may be obtained, at least partly, from 
the sequence of events including progesterone- and U18666A-induced accumulation of 
cholesterol, decrease in ATP/ADP ratio, cytochrome c and Smac/Diablo release and 
caspase activation. Accumulation and sequestration of cholesterol, as determined by 
filipin staining, became evident 6 h after exposure of the neurons to the amphiphiles 
(Figure 3.4). This was apparently followed by a decrease in ATP biosynthesis and release 
of cytochrome c and Smac/Diablo (all significantly evident at 12 h; Figure 3.6 and Figure 
3.8). Both the initiator caspase-9 and the effector caspase-3 were then activated thereafter 
(significantly evident at 24 h, Figure 3.7 and Figure 3.10), while initial neuronal cell 
death as measured by MTT assay was observed at 24 h post-treatment (Figure 3.3). If 
impairment of mitochondrial function and the subsequent events leading to the neuronal 
cell death described above were triggered by the amphiphile-induced interruption to 
cholesterol intracellular trafficking, removal of the triggering factors should help to 
prevent the neurons from death. This was indeed the case as shown by progesterone 
washout (Figure 3.5). In order to avoid triggering neuronal cell death, however, removal 
of progesterone had to be performed in time before the injury to the mitochondria became 
 71
irreversible. These results are consistent with past observations in which no significant 
cell injury was found in cortical neurons exposed to U18666A for 8 h (Runz et al., 2002), 
while prolonged treatment with the same amphiphile resulted in apoptosis of the neurons 
(Cheung et al., 2004).   
        
The release of pro-apoptotic factors such as cytochrome c, Smac/Diablo and AIF from 
the injured mitochondria triggers the mitochondrial apoptosis cascade. Cytochrome c 
released into the cytosol promotes caspase-3 activation through the formation of 
cytochrome c/Apaf-1 apoptosome complex that activates procaspase-9, whereas 
Smac/Diablo acts as a sensitizer for  caspase activity following cytochrome c-induced 
activation of caspase-9 by binding to inhibitor of apoptosis proteins (IAPs), thereby 
antagonizing the inhibitory effect of IAPs on the activation of effector caspases. Both 
cytochrome c and Smac/Diablo are involved in caspase-dependent apoptosis, while AIF 
plays a central role in mediating the caspase-independent apoptosis pathway (van Loo et 
al., 2002; Saelens et al., 2004; Cregan et al., 2004). Apparently, progesterone- and 
U18666A-induced injury to mitochondria was not sufficient to cause AIF release (Figure 
3.9). In this regard, it has recently been reported that permeabilization of the 
mitochondrial outer membrane readily causes translocation of cytochrome c and 
Smac/Diablo, whereas AIF remains bound to mitochondria, probably because mature AIF 
is a type-1 inner mitochondrial protein and proteolytic cleavage is necessary for AIF 
release (Arnoult et al., 2002; Uren et al., 2005; Otera et al., 2005; Polster et al., 2005; 
Yuste et al., 2005). The different kinetics of cytochrome c and AIF release were also 
reported in cortical neurons undergoing p53-mediated cell death (Cregan et al., 2002). 
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Another important mechanistic issue is related to the observation that AIF was not 
released at the activation of caspase-9 and caspase-3, suggesting that caspase activation, 
in addition to outer membrane permeabilization, was insufficient to cause AIF release, in 
contrast to some previous reports (Arnoult et al., 2002; 2003a; 2003b) but in agreement 
with the observations by others (Uren et al., 2005). Taken together, one may hypothesize 
that the precise molecular mechanism of mitochondrial apoptosis cascade may depend 
upon the extent of mitochondrial damage, which in turn is determined by the nature of the 
cell death stimuli.  
        
In progesterone- and U18666A-treated cortical neurons, both caspase-9 and caspase-3 
were activated. When either of these two caspases was blocked by specific inhibitors, 
neuronal cell death was inhibited (Figure 3.7 and Figure 3.10). Furthermore, inhibition of 
caspase-9 by taurine led to lack of activation of caspase-3 (Figure 3.10A), indicating that 
the latter was the downstream effector caspase of the former. All these observations are 
widely believed as the features for apoptosis in the nervous system (Yuan and Yankner, 
2000).  In addition, both in vitro treatment of the neurons with the amphiphiles and in 
vivo analysis of the NPC1 mouse neurons revealed the deterioration of neuronal 
mitochondrial function (Figure 3.6; Yu et al., 2005), which was believed being induced 
by disruption of the intracellular cholesterol homeostasis and to be responsible for 
neurodegeneration in NPC1 disease. Taken together, the model system used in this study 
should have represented the essential features of neuronal cell death in NPC1 disease. 
The mitochondrial apoptosis cascade described here is therefore likely to represent at 
least one of the neuronal cell death pathways in this disorder. It should be pointed out that 
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the molecular mechanism leading to apoptosis in the brain of NPC disease may be 
distinct in terms of the types of neurons. In NPC-/- mice, although apoptotic cells could be 
detected in the cerebellum and cerebral cortex, loss of Purkinje cells are much more 
severe and faster than other neurons (Wu et al., 2005; Li et al., 2005), implying that 
neuronal apoptosis in different regions of the brain may be regulated differently.  
      
Elucidation of the molecular events that control the neuronal death is essential for 
development of therapeutic strategies for treatment of these neuronal disorders including 
NPC1 disease. I have shown that caspase-dependent neuronal apoptosis might be caused 
by impaired mitochondrial function due to disrupted intracellular cholesterol trafficking, 
whereas caspase-independent neuronal cell death was not involved. Therefore, effective 
therapeutics should target the caspase-dependent pathway. It is interesting to note that 
taurine, which is known to perform neuroprotective roles in mammalian brains (Khan et 
al., 2000; Shuaib, 2003), rescued the amphiphile-insulted neurons from apoptotic death 
(Figure 3.10B), apparently by inhibiting activation of caspase-9 (Figure 3.10). It also 
prevented the neurotoxicity of -amyloid in Alzheimer’s disease (Louzada et al., 2004), a 
neurological disorder, like NPC disease, in which intracellular cholesterol trafficking is 
considered as a risk factor (Runz et al., 2002; Burns et al., 2003). Taking these findings 
together, it should be worth exploring taurine as a promising treatment for NPC1 disease 
and other neurological disorders correlated with abnormal cholesterol metabolism. 
       
In summary, I have demonstrated that inhibition of intracellular cholesterol trafficking 
induces neuronal cell death through the mitochondrial apoptosis pathway in a caspase-
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dependent manner. Moreover, it was also shown that targeting caspase-9 activation and 
activity of apoptosome by taurine provides neuroprotection that may represent a new 









Chapter 4. Protection effect of cAMP and forskolin on neurons 
and NPC1 fibroblasts  
 
 
4.1.   Introduction 
  
Cell-permeable analogues of cAMP have been shown to improve the survival of cells 
( Nakao N, 1998; Vaudry D, et al., 1998; Michel PP, et al., 1996; Schildberg FA, et al., 
2005). The NPC-1 gene is upregulated by cAMP, which plays a role in normal 
cholesterol homeostasis and is essential for normal adrenal development and function 
(Gévry NY and Murphy BD, 2002). cAMP, also coordinately enhances the expression of 
Rab5a and Rab7, which promote Tg endocytosis and transfer to lysosomes, respectively, 
resulting in accelerated thyroid hormone production (Croizet-Berger K, et al., 2002). 
Extracellular signal-regulated protein kinase 1 and 2 (ERK1/2), which are members of 
the mitogen-activated protein kinase superfamily, have been well characterized and are 
known to be involved in cell survival. The cAMP-->ERK-->CREB cascade may thus 
constitute a molecular integrator for converging signals. However, the effect of cAMP on 
ERK phosphylation still remains controversial. A study has shown that cAMP treatment 
reduced phosphorylation of ERK in human endothelial cells (Schildberg et al., 2005). 
Moreover, recent evidence suggests that activation of ERK1/2 also contribute to cell 
death in some cell types and organs under certain conditions (Jin KL, et al., 2002). 
Sawamura N, et al. showed that the activation of Erk1/2 has shown to promote tau 
phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in 
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detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells (Sawamura et 
al., 2003); the hyperphosphorylated tau was the major component for the formation of 
neurofibrillary tangles, indicating a pathological hallmark of Alzheimer’s disease. In our 
first part of study, I showed that inhibition of intracellular cholesterol trafficking induces 
neuronal cell death through the mitochondrial apoptosis pathway in a caspase-dependent 
manner. The U18666A treatment on cortical neuron mimic the NPC1 phenotype. I further 






4.2.1. cAMP and forskolin promote neuronal cell survivals.  
 
I have showed U18666A induced neuronal cell death (Huang Z, et al., 2006). In the 
present study, I further examined whether the cell death could be rescued by cAMP or 
forskolin (Branton et al., 1998; Schildberg et al., 2005). 
 
The cultured neuron was pre-incubated with 0.3 mM cAMP or 20 μM forskolin for 30 
min, thereafter, U18666A was added to culture medium with a final concentration of 2 
μg/ml, neuron was further incubate for 12-72 h. In the absence of cAMP or forskolin, 
U18666A induced cell death occurred at 24 h, 48 h and 72 h, consistent with our previous 
result. Interestingly, in the presence of cAMP or forskolin, neuronal cell death was 
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reduced. As compared to U18666A treatment alone, co-treatment of U18666A with 







































Figure 4.1 Effect of cAMP and forskolin on neuronal cell survivals. 
Neuron was preincubated with cAMP 0.3 mM and Forskolin 20 μM or 0.5h, followed by 
addition of U18886A to medium with a final concentration of 2 μg/ml. Neuron was 
treated for 12-72 h. All data reporesent the mean ± SE of three independent experiments. 
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4.2.2. Effect of cAMP and forskolin treatment on neuronal intracellular free 
cholesterol  
     
To examine whether cholesterol accumulation in the cortical neurons has reduction upon 
addition of cAMP or forskolin. Our previous result show  impairment of mitochondrial 
function, the unesterified cholesterol was stained with filipin and cholesterol 
accumulation was observed as early as 6 h after exposure of the neurons to 2 g/ml 
U18666A (Figure 4.2). In the presence of cAMP or forskolin, U18886A induced free 
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Figure 4.2  Effect of cAMP or forskolin on intracellular cholesterol accumulation. 
Accumulation of intracellular cholesterol was observed in cortical neurons 6 h after 
treatment with U18666A (2g/ml), less accumulation in case of co-treatment of cAMP 
with U18666A or forskolin with U18666A. Bar = 10 m; Arrows: accumulated 








4.2.3. Rgulation of cAMP and forskolin on the expression of rab7, rab9, rab5 and 
rab11 in neuron 
 
The reduction of free cholesterol accumulation led me to further investigate the Rab 
proteins in the intracellular cholesterol trafficking path, a few candidates of Rab proteins 
were selected, such as Rab7, Rab9, Rab 5 and Rab 11. I treated neurons with U18666A 
2ug/ml, or co-treatment with either cAMP 0.3 mM or forskolin 20 μM for 6h, 24h, 48h 
and 72h. Rab7, which mediate intracellular transportation from endosome to lysosome, 
was up-regulated with treatment of cAMP or forskolin. This upregulation effect is more 
apparent in the 48 h or 72 h time point (Figure 3.4 A). However, with the treatment of 
cAMP and forskolin, Rab9 expression level had mild changes only (Figure 3.4 A), and 
Rab5 and Rab11 were not significant changes (Figure 3.4 B). 
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Figure 4.3 Effect of cAMP or forsolin on the expression of rab7, rab9, rab5 and 
rab11 in neuron by western blotting.  Neuron was treated for 6h, 24h, 48h and 72h, 
with U18666A 2ug/ml, or co-treatment with either cAMP 0.3 mM or forskolin 20 μM.  





4.2.4. Effect of cAMP and forskolin treatment  on [H3] cholesteryl oleate 
 formation in neuron 
 
The neurons were treated with various reagents for 32h and co-incubated with [3H]oleic 
acid (1 μCi/ml) at 37 °C for further 16 h. Lipid extracted by Chloroform/methanol was 
separated by thin-layer chromatography. The radioactivity of cholesteryl oleate was 
measured by liquid scintillation counting (Kitatani K, et al. 2002). Figure 4.4 A showed 
that cholestryl oleate increase with cAMP or forskolin alone increased by 4-5 folds. With 
co-incubation of cAMP with forskolin, the increase of cholesteryl oleate was 3-4 folds, as 
compared to U18666A treatment. This explained the reduction of free cholesterol 
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accumulation in figure 4.2. To examine whether Rab7 has an important role in 
transportation of free cholesterol, I have knocked down Rab7 by siRNA (Figure 4.4B). 
The efficiency of siRNA was examined by western blotting. Upon knock down of Rab7, 
the induction of cAMP or forskolin has much less effect on choleteryl oleate formation as 
compared to no-treatment control (no-drug, no-siRNA), while with knock down with not 
specific target gene, has no effect on Rab7 and cholesteryl oleate formation remain 2-3 
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Figure 4.4 Effect of cAMP and forskolin treatment  on [H3] cholesteryl oleate      




4.2.5. Effect of cAMP and forskolin on ERK phosphorylation  
 
I further examine ERK phosphorylation by cAMP (0.3 mM) and forskolin (20 μΜ) 
stimulation. Western blotting showed co-treatment of cAMP or forskolin with U18666A 
activated ERK. The activation of ERK occurred at 10 min treatment, and it sustained to 
60min (Figure 4.5), even to a longer period of 24 h (data not shown).  
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Figure 4.5 Activation ERK with stimulation of cAMP or forskolin. C: no-treated 
control; U: U18666A 2 μg/ml; cAMP: 0.3 mM; Fors: forskolin 20 μM. 
 
4.2.6. Effect of inactivation of ERK on  cholesteryl oleate formation       
PD98059 is the inhibitor of MEK 1/2, which in turn would inhibit ERK activation.  
I further examined whether ERK activation has effect on cholesteryl oleate formation. 
Figure 4.6 showed neurons with cAMP or forskolin alone, will have about 2-3 fold of 
cholesteryl oleate formation as compared to the no-treated control. However, with the 
addition of inhibitor PD98059 (20 μM)  to cAMP or forskolin, the cholesteryl oleate 
formation return to baseline as no-treated control, indicating phosphorylation of ERK 
could be a up-stream activator, which would play a role in the intracellular cholesterol 
transportation. 
  




















































Figure 4.6 Effect of inactivation of ERK on  cholesteryl oleate formation 
pERK  42kD 
                  44kD           
ERK  
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C: no-treated control; U: U18666A 2 μg/ml; cAMP: 0.3 mM; Fors: forskolin 20 μM. 
 
4.2.7. Up-regulation of cAMP and forskolin on Rab7 expression and cholesteryl 
oleate formation in NPC1 fibroblast  
 
NPC1 deficient cell line GM3123 was chosen to study the effect of cAMP and forskolin 
on Rab7 expression. NPC1 fibroblast was treated with cAMP or forskolin in the presence 
or absence of LDL, Expression of Rab7 was detected by Western blotting at 48 hour 
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Figure 4.7 Effect of cAMP and forskolin on Rab7 expression and cholesteryl oleate 
formation in NPC1 fibroblast with 48 hour treatment. (A) Western blot analysis of 
Rab7 expression; (B) Quantitative analysis of Rab7 expression level, the mean expression 
level of Rab7 in untreated cells was set as 100%. Values are mean±SE.  C: non-treated, 
incubated with LPDS medium; LDL: low density lipoprotein 50 μg/ml; cAMP: cyclic 
AMP 0.3 mM; Fors: forskolin 20 μM. Western blotting with anti-Rab7, β-actin used as a 





4.2.8. Effect of cAMP and forskolin on intracellular free cholesterol and cholesteryl 
oleate formation in NPC1 fibroblasts  
Up-regulation of Rab7 could help cholesterol intracellular transportation, filipin staining 
on firbroblast treated with cAMP 0.3 mM or forskolin 20 μM for 48 hour, in the presence 
of low density lipoprotein (LDL) 50 μg/ml. LDL incubation could induce mass amount of 
free cholesterol accumulation in NPC1 (-/-) fibroblast. With co-incubation of cAMP or 
                 *                    *         
       *                                          *    
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forskolin, free cholesterol accumulation was significantly reduced (Figure 4.8A), which 
was consistent with increase of cholesteryl oleate formation (Figure 4.8B). However, 
with the siRNA knock-down of Rab7 (efficiency of siRNA showed in Figure 4.7), the 
cholesteryl oleate formation returned to baseline close to non-treated NPC1 (-/-) 
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Figure 4.8  Effect of cAMP and forskolin on intracellular free cholesterol and 
cholesteryl oleate formation in NPC1 fibroblast with 48 hour treatment.  C: non-
treated, with LPDS medium; LDL: low density lipoprotein 50 μg/ml; cAMP: cyclic AMP 
0.3 mM; Fors: forskolin 20 μM.  
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4.2.9. Effect of cAMP and forskolin on ERK phosphorylation and cholesteryl oleate 
formation in NPC1 fibroblasts 
 
In case of NPC1(-/-) fibroblasts, cAMP or forskolin stimulate ERK phosphorylation at 30 
min as shown in Figure 4.9A. In the presence of LDL, cAMP (0.3 mM) or forskolin (20 
μM) increase cholesteryl formation for about 5 folds (Figure 4.9) at the time-point of 48 
hour treatment. PD98059 was known to inhibit MEK 1/2 kinase, which in turn inactivate 
ERK. With the addition of PD98059 (20 μM), cholesteryl oleate formation was 
significantly reduced by about 2-3 fold to a much lower level, which was observed at 
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Figure 4.9 Effect of cAMP and forskolin on ERK phosphorylation and cholesterol 
oleate formation in NPC1 fibroblast. C: no-treated control, incubated with LPDS 
medium; LDL: low density lipoprotein 50 μg/ml; cAMP: cyclic AMP 0.3 mM; forskolin: 
20 μM; PD: PD98059 20 μM
pERK     42Kd 
                      44kD       




I have explored the biochemical events occurring after induction of neuronal apoptosis in 
primary cortical neurons after treatment with U18666A. This drug leads to an inhibition 
of cholesterol trafficking, results in the accumulation of cholesterol in normal cells, and is 
commonly used to mimic the cellular effects of NPC (Liscum et al, 1989; Lange et al., 
2000; Mohammadi 2001). 
 
Cell-permeable analogues of cAMP have been shown to improve the survival of cells 
( Nakao 1998; Vaudry et al., 1998; Michel et al., 1996; Schildberg et al., 2005). The 
NPC-1 gene is up regulated by cAMP, which plays a role in normal cholesterol 
homeostasis and is essential for normal adrenal development and function (Gévry and 
Murphy 2002).  
 
In the present study, I had further examined whether the cell death could be rescued by 
cAMP or forskolin. The cultured neuron was pre-incubated with 0.3 mM cAMP or 20 uM 
forskolin and/or U18666A 2μg/ml for 12-72 h. In the absence of cAMP or forskolin, 
U18666A induced cell death occurred at 24 h, 48 h and 72 h, consistent with our previous 
result. Interestingly, in the presence of cAMP 0.3 mM or forskolin 20 μM, neuronal cell 
death was reduced by approximate 10% at 24 h, 20% at 48h, and 30% at 72h, as 
compared to U18666A treatment alone (Figure 4.1). Co-treatment of U18666A with 
cAMP or forskolin, has significantly promote cell survivals.  
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Promotion of cell survival by cAMP or forskolin could be via ERK1/2 signaling. ERK 
are members of the mitogen-activated protein kinase superfamily, have been well 
characterized and are known to be involved in cell survival (Jin et al., 2002; Jiang et al., 
2005; Park and Cho 2006; Zhang and Abdel-Rahman 2008). Especially, ERKs are 
involved in a wide range of neuronal functions including differentiation, synaptic 
plasticity, survival, migration (Thelen et al, 2002), and long-term changes in gene 
expression (Hevroni et al., 1998) that may underlie aspects of learning and memory 
(Impey et al., 1999). For example, studies showed cAMP activation of ERKs mediates 
some of the neuroprotective actions of selected hormones and neurotransmitters (Elliott-
Hunt, et al., 2002; Troadec et al., 2002). Forskolin, an adenylate cyclase activator, was an 
agent that increases intracellular levels of cAMP, protects keratinocytes from UVB-
induced apoptosis independently from the amount of melanin in the skin (Passeron et al., 
2008). Forskolin could induce late long-term potentiation in hippocampal neurons via 
ERK, and PI3K in hippocampal pyramidal cells (Gobert 2008). However, the effects of 
cAMP on ERK phosphorylation still remain controversial. Study has shown that cAMP 
treatment reduced phosphorylation of ERK in human endothelial cells (Schildberg et al., 
2005). Moreover, recent evidence suggests that activation of ERK1/2 also contribute to 
cell death in some cell types and organs under certain conditions. Garg and Chang 
showed that oxidative stress causes ERK phosphorylation and cell death in cultured 
retinal pigment epithelium (Garg and Chang, 2003). Sawamura et al. showed that the 
activation of Erk1/2 has shown to promote tau phosphorylation by MAP kinase Erk1/2 is 
accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in 
Niemann-Pick C1-deficient cells (Sawamura et al., 2003), the hyperphosphorylated tau 
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was the major component for the formation of neurofibrillary tangles, indicating a 
pathological hallmark of Alzheimer’s disease. In our first part of study, I showed that 
inhibition of intracellular cholesterol trafficking induced neuronal cell death through the 
mitochondrial apoptosis pathway in a caspase-dependent manner. Arany I et al. 
demonstrated that cisplatin-induced cell death is EGFR/src/ERK signaling dependent in 
mouse proximal tubule cells, and suggested that the prodeath effect of ERK is injury type 
dependent (Arany et al., 2004). 
 
I am interested to further examine the effect of ERK phosphorylation by cAMP (0.3 mM) 
and forskolin (20 μΜ) stimulation in our case. Western blotting showed co-treatment of  
cAMP or forskolin with U18666A activated ERK. The activation of ERK occurred at 10 
min treatment, and it sustained to 60min (Figure 4.5), even to a longer period of 24 h 
(data not shown). Our result was consistent with the studies done by others. It has been 
report that N-acetyl-O-methyldopamine (NAMDA) enhances forskolin-induced ERK-
CREB activation and potentiated forskolin-induced resistance to apoptosis. The study 
indicated that enhancing endogenous survival pathways by NAMDA combined with 
other neuroprotective measure(s) might be a useful strategy to reduce apoptosis (Park and 
Cho, 2006). Activation of the ERK signaling cascade indicates that visceral primary 
afferents may sensitize after gastric noxious stimulation involving N-methyl-D-aspartate 
receptors. The ERK pathway therefore may not only be of importance for somatic but 
also for visceral nociception (Schicho et al., 2005). Spatiotemporal distribution of 
cerebellar pERK-IR suggesting that the ERK-pathway plays a dynamic role in regulating 
neuronal and glial migration, proliferation and differentiation in the developing 
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cerebellum. In the mature cerebellum, ERK signaling may also mediate postsynaptic 
information processing (Zsarnovszky and Belcher 2004). There is a study showed that 
cAMP promotes neurite outgrowth and extension through protein kinase A but 
independently of ERK activation in cultured rat motoneurons (Aglah et al., 2008). The 
ability of cAMP/PKA to activate ERKs in neuronal cells appears to depend on the 
development stage (Vogt Weisenhorn, et al., 2001), which might explain some 
controversial on the effect of ERK on cell survivals. 
 
My previous study has shown intracellular cholesterol accumulation is related to neuronal 
apoptosis. The death mechanism through mitochondrial dysfunction has been illustrated. 
Addition of cAMP or forskolin protects neuronal cell death, likely via ERK signaling 
pathway. I further examine whether cAMP and forskolin have effect on attenuation of 
intracellular cholesterol accumulation. Accumulation of intracellular cholesterol was 
observed in cortical neurons after treatment with U18666A (2g/ml), much less 
accumulation in case of co-treatment of cAMP with U18666A or forskolin with 
U18666A (figure 4.2), the intracellular cholesterol homeostasis could be restored.  
 
Rab family is involved in multiple trafficking events in both endocytotic and biosynthetic 
pathways, and is located in specific intracellular compartments. Rab5 is involved in early 
endosome function, Rab4, Rab11 are involved in the sorting/recycling endosome, and 
Rab7 is involved in the lysosome/vacuole as the target organelle for degradation. 
Cholesterol contributes to regulate the Rab7 cycle, and that Rab7 in turn controls the net 
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movement of late endocytic elements. Motor functions can be regulated by the membrane 
lipid composition via the Rab7 cycle (Lebrand et al., 2002). 
 
Studies showed Thyroid-stimulating hormone via cAMP, or forskolin increased Rab5a 
and Rab7 expression. (Croizet-Berger et al., 2002); overexpression of wild-type Rab7 or 
Rab9, but not Rab11, in Niemann-Pick type C lipid storage disease fibroblasts resulted in 
correction of lipid trafficking defects, including restoration of Golgi targeting of 
fluorescent lactosylceramide and endogenous GM1 ganglioside, and a dramatic reduction 
in intracellular cholesterol stores (Choudhury et al., 2002; Narita et al., 2005). The 
correction of membrane traffic in NPC cells by Rab protein overexpression may lead to 
new therapeutic approaches for treatment of this disease. 
 
A few candidates of Rab proteins were selected in our study, such as Rab7, Rab9, Rab 5 
and Rab 11. I treated neuron with U18666A 2ug/ml, or co-treatment with either cAMP 
0.3 mM or forskolin 20 μM for 6h, 24h, 48h and 72h. Western blot showed that Rab5 and 
Rab11 were not significant changes with the induction of cAMP or forskolin, whereas 
Rab 9 expression level had mild changes. Rab7, which mediate intracellular 
transportation from endosome to lysosome, was up-regulated with co-treatment of cAMP 
or forskolin. This up-regulation effect is more apparent in the 48 h or 72 h time point 
(Figure 4.5). This is the first study I showed cAMP and forskolin has effect on Rab7 
expression in the cultured cortical neurons.  
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Both activation of ERK and Rab7 has increased intracellular cholesterol esterification. 
This was confirmed with the inhibition of ERK activation by PD98059, choleteryl oleate 
formation in neuron was reduced; while knock-down of Rab7 by siRNA similar results 
shown. Both ERK activation and Rab7 may play roles in cholesterol transportation and 
esterification, through direct or indirect effects. Further studies should be carried out on 
the association between Rab7 upregulation and ERK phosphorylation, the mechanism of 
Rab7 upregulation, and also exam the mitochondria function as mitochondrial 
dysfunction shown in progesterone or U18666A induced neuronal apoptosis. Thus, 
therapies targeting basic mitochondrial processes, such as energy metabolism or free-
radical generation, or specific interactions of disease-related proteins with mitochondria, 
may hold promise. 
 
The system that I used for U18666A treatment on cortical neuron is a model that mimics 
the NPC1 phenotype, therefore, NPC1 (-/-) fibroblasts were chosen to be an in vitro 
system to study the effect of cAMP and forskolin. In the present study, Western blot 
showed cAMP or forskolin increase Rab7 about 2 folds at 48 hours treatment (Figure 4.7). 
Free cholesterol accumulation in the NPC1 fibroblast also apparently reduced (Figure 
4.2); while cholesterol esterification was increased by about 3-4 fold. Knock-down of 
Rab7 by siRNA, showed the impact on cholesterol esterification too (Figure 4.8B), 
indicating Rab7 was required to transport free cholesterol for esterification. cAMP or 
forskolin also activation ERK in NPC1 fibroblast, inhibition of ERK activation by 
PD98059 is concurrently occurred with reduction of cholesteryl oleate formation, 
indicating that phosphorylation of ERK could be a  up-stream factor of cholesterol 
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esterification. Further studies should be carried out on the association between Rab7 
upregulation and ERK phosphorylation. A comparison of candidate Rab proteins between 
normal fibroblast and NPC1 (-/-) fibroblast may be worth to carry out. If possible, study 
can be extended to a translational level, from bench to bedside, one may get more 
valuable information on the regulation of cholesterol transportation, and apply such 
information on therapeutic strategies. 
 
Thus, therapies targeting basic mitochondrial processes, such as energy metabolism or 
free-radical generation, or specific interactions of disease-related proteins with 




Charpter 5. Conclusions 
 
 
Elevated level of cholesterol in mitochondrial membranes of Niemann-Pick disease type 
C1 (NPC1) mouse brains and neural cells has been found to cause mitochondrial 
dysfunction. In the first part of the present study, I demonstrated in this study that 
inhibition of intracellular cholesterol trafficking in primary neurons by class 2 
amphiphiles, which mimics the major biochemical and cellular feature of NPC1, led to 
not only impaired mitochondrial function but also activation of the mitochondrial 
apoptosis pathway. In activation of this pathway both cytochrome c and Smac/Diablo 
were released but apoptosis-inducing factor (AIF) was not involved. Treatment of the 
neurons with taurine, a caspase-9 specific inhibitor, could prevent the amphiphile-
induced apoptotic cell death, suggesting that formation of apoptosome, followed by 
caspase-9 and caspase-3 activation, might play a critical role in the neuronal death 
pathway. Taken together, the mitochondria-dependent death cascade induced by blocking 
intracellular cholesterol trafficking was caspase-dependent.  
 
Cell-permeable analogues of cAMP have been shown to improve the survival of cells, via 
ERKs mediates some of the neuroprotective actions of selected hormones and 
neurotransmitters. cAMP also coordinately enhances the expression of Rab5a and Rab7, 
which promote Tg endocytosis and transfer to lysosomes, respectively, resulting in 
accelerated thyroid hormone production. In our second part of study, I found cAMP and 
forskolin were effective in rescue neuronal injury induced by U18666A, concurrently 
with reduction of free cholesterol accumulation and increase of cholesterol esterification 
in both U18666A induced mimic model (cortical neuron) and npc1 (-/-) fibroblast, via 
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activation of ERK and up-regulation of Rab7 expression. These findings in the present 
study provide clues for both understanding the molecular basis of neurodegeneration in 
NPC1 disease and developing therapeutic strategies for treatment of this disorder. 
Further studies should be carried out on the association between Rab7 up-regulation and 
ERK phosphorylation, the mechanism of Rab7 up-regulation, as well as the effect of 
cAMP and forskolin on the mitochondria function. Therapies targeting basic 
mitochondrial processes, such as energy metabolism or free-radical generation, or 
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